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The regulatory gene for pyrimidine biosynthesis has been identified and
designated pyrR.  The pyrR gene product was purified to homogeneity and found to have
a monomeric molecular mass of 19 kDa.  The pyrR gene is located directly upstream of
the pyrBC' genes in the pyrRBC' operon.  Insertional mutagenesis of pyrR led to a 50-
70% decrease in the expression of pyrBC', pyrD, pyrE and pyrF while pyrC was
unchanged.  This suggests that PyrR is a positive activator.  The upstream regions of the
pyrD, pyrE and pyrF genes contain a common conserved 9 bp sequence to which the
purified PyrR protein is proposed to bind.  This consensus sequence is absent in pyrC but
is present, as an imperfect inverted repeat separated by 11 bp, within the promoter region
of pyrR.  Gel retardation assays using upstream DNA fragments proved PyrR binds to the
DNA of pyrD, pyrE, pyrF as well as pyrR.  This suggests that expression of pyrR is
autoregulated; moreover, a stable stem-loop structure was determined in the pyrR
promoter region such that the SD sequence and the translation start codon for pyrR is
sequestered.  β-galactosidase activity from transcriptional pyrR::lacZ fusion assays,
showed a two-fold in increase when expressed in a pyrR- strain compared to the isogenic
pyrR+ strain.  Thus, pyrR is negatively regulated while the other pyr genes (except pyrC)
are positively activated by PyrR.  That no regulation was seen for pyrC is in keeping with
the recent discovery of a second functional pyrC that is not regulated in P. aeruginosa.
Gel filtration chromatography shows the PyrR protein exists in a dynamic
equilibrium, and it is proposed that PyrR functions as a monomer in activating pyrD,
pyrE and pyrF and as a dimeric repressor for pyrR by binding to the inverted repeat.  A
related study discovered that the catabolite repression control (Crc) protein was indirectly
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The pseudomonads are a group of obligate aerobes that use oxygen as the final
electron acceptor.  Some members can also use nitrate in lieu of oxygen in anaerobic
respiration and thus can grow anaerobically.  The genus is non-fermentative and near
ubiquitous in soil and water.  A striking feature of the genus is extreme nutritional
versatility of its member species, in particular Pseudomonas aeruginosa, the subject of
this dissertation.  The biochemical studies of Stanier et al., (1966) provided the early
evidence for the physiological diversity of the aerobic pseudomonads and revealed the
capacity of Pseudomonas species to metabolize a wide range of low-molecular weight
organic compounds.  Some species metabolize over 100 different compounds, and
Pseudomonas aeruginosa in particular, has the ability to utilize numerous classes of
compounds as carbon and energy sources such as sugars, fatty acids, dicarboxylic acids,
tricarboxylic acids, some alcohols, polyalcohols and glycols, aromatic compounds, amino
acids, amines and other organic molecules.  In addition to being able to grow at
temperatures as high as 43°C, P. aeruginosa and some other Pseudomonas species can
grow in temperatures as low as 4°C.  This physiological and genetic adaptability makes
many pseudomonads important as pathogens of both plants and animals (Spiers et al.,
2000; Yamamoto et al., 2000).  The type species, P. aeruginosa is a recently designated
global pathogen (Goldberg, 2000) and in humans it acts opportunistically by initiating
infections
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in individuals whose resistance is low.  The production of the exopolysaccharide alginate
is known to play several roles in the pathogenicity of P. aeruginosa, and its conversion to
mucoidy is the major cause of infections in cystic fibrosis (CF) patients (Pederson, 1992;
Koch & Høiby, 1993).  Moreover, P. aeruginosa produces a green pigment known as
pyoverdin that is also a major factor in virulence.
In the absence of the conventional Embden-Meyerhof-Parnas (EMP) mode of
glycolysis, pseudomonads employ a number of alternative catabolic pathways to utilize
carbohydrates, especially glucose and gluconate as carbon and energy sources.  In P.
aeruginosa, the Entner-Doudoroff pathway (ED) is the central metabolic route for the
dissimilation of glucose to pyruvate and glyceraldehyde-3-phosphate (Entner &
Doudoroff, 1952; Conway, 1992).  The first step of glucose metabolism in P. aeruginosa
is the conversion of glucose to glucose-6-phosphate by the glk-encoded glucokinase,
followed by the formation of 6-phosphogluconate catalyzed by the zwf-encoded glucose-
6-phosphate dehydrogenase.  The next step involves the first of the two ED specific
enzymes 6-phosphogluconate dehydratase, encoded by edd which converts of 6-
phosphogluconate to 2-keto-3-deoxy-6-phosphogluconate (KDPG).  The second specific
enzyme aldolase, encoded by eda catalyzes the formation of pyruvate and
glyceraldehyde-3-phosphate.  These compounds, are then further metabolized by the




Pyrimidine and purine nucleotides are the essential substrates for the
informational macromolecules ribonucleic acid (RNA) and deoxyribonucleic acid (DNA)
which are required for cellular growth, and for the transmission of genetic information to
succeeding generations.  Two main pathways are involved in the formation of pyrimidine
ribonucleotides, namely the biosynthetic pathway (Fig. 1) and the salvage pathway (Fig.
2).  The biosynthetic pathway produces uridine 5’-triphosphate (UTP), cytidine-5’-
triphosphate and deoxythymidine-5’-triphosphate (dTTP) and deoxycytidine-5’-
triphosphate (dCTP), while the salvage pathway is responsible for the recycling of
pyrimidine compounds released primarily from the degradation of messenger RNA.  The
biosynthetic pathway has been studied extensively in bacteria (Yates & Pardee, 1956a,
1956b, 1957; Beckwith et al., 1962; Hayward & Belser, 1965; Yan & Demerec, 1965;
Hutson & Downing, 1968; Foltermann et al., 1981; Grogan & Gunsalus, 1993), fungi
(Lacroute, 1968; Caroline, 1969), plants (Kafer & Thornburg, 1999) and mammals
(Hager & Jones, 1967; Nakinishi et al., 1968; Jones, 1980).  This pathway is ubiquitous
except for a few obligate parasites (Jones, 1980) and follows the same sequence in all
organisms studied thus far (Grogan & Gunsalus, 1993; O’Donovan & Neuhard, 1970).
However, although the sequences are almost the same, variation exists in the regulation
and organization of the enzymes within different organisms.
The salvage pathway has been studied in detail by Beck (1995) in more than 40




































Fig. 1.  The pyrimidine biosynthetic pathway in Pseudomonas aeruginosa.  The gene
symbols and enzymes they encode: 1, pyrA (carAB) – carbamoylphosphate synthetase
(CPSase);  2, pyrBC’ – aspartate transcarbamoylase (ATCase);  3, pyrC – dihydroorotase
(DHOase);  4, pyrD – dihydroorotate dehydrogenase (DHOdehase);  5, pyrE – orotate
phosphoribosyltransferase (OPRTase);  6, pyrF – OMP decarboxylase (OMPdecase);  7,
pyrH – UMP kinase;  8,  ndk – nucleoside diphosphate kinase;  9, pyrG – CTP synthase.
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Fig. 2.  The pyrimidine salvage pathway in P. aeruginosa.  Gene symbols and the
enzymes they encode:  1, upp – uracil phosphoribosyltransferase (UPRTase);  2, nuh –
nucleoside hydrolase;  3, codA – cytosine deaminase;  4, 5’-nucleotidase;  5, cmg – CMP


























differ from organism to organism.  While the pyrimidine biosynthetic pathway is missing
in some obligate parasites, no organism is completely devoid of a salvage pathway.
Pyrimidine biosynthetic pathway
The first step of pyrimidine biosynthesis involves carbamoylphosphate synthetase
(CPSase) which catalyzes the reaction between bicarbonate and ammonium ions or more
favorably glutamine, and two molecules of adenosine-5’-triphosphate (ATP) to form one
molecule of carbamoylphosphate and adenosine-5’-diphosphate (ADP) (Anderson &
Meister, 1965; Kalman et al., 1966).  Both the arginine and pyrimidine biosynthetic
pathways require carbamoylphosphate (Abdelal et al., 1969).  The next step in the
pyrimidine pathway involves the carbamoylation of the amino group of aspartate to give
carbamoylaspartate and an inorganic phosphate molecule.  This reaction is catalyzed by
aspartate transcarbamoylase (ATCase) and is the first step unique to pyrimidine
biosynthesis.  The third reaction involves the cyclization of carbamoylaspartate with the
elimination of a molecule of water to produce dihydroorotate, a reaction catalyzed by the
enzyme dihydroorotase (DHOase).  The fourth step of the process is the oxidation of
dihydroorotate to orotate by the enzyme dihydroorotate dehydrogenase (DHOdehase).
Next, the transfer of ribose-5’-phosphate from 5’-phosphoribosyl-1’-pyrophosphate
(PRPP) to orotate forms orotidine-5’-monophosphate (OMP), a reaction catalyzed by
orotate phosphoribosyltransferase (OPRTase).  The decarboxylation of OMP by the
enzyme OMP decarboxylase (OMPdecase) in the next step produces uridine-5’-
monophosphate (UMP), which serves as a precursor for all pyrimidine nucleotides
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including the pyrimidine nucleoside triphosphates, uridine-5’-triphosphate (UTP) and
subsequently cytidine-5’-triphosphate (CTP).  In sequential steps, UMP is
phosphorylated to uridine-5’-diphosphate (UDP) by the highly specific UMP kinase, then
further phosphorylation by the non-specific nucleoside diphosphate kinase yields UTP.
The transfer of an amino group from glutamine by the enzyme CTP synthetase,
completes the pathway converting UTP to CTP.
Pseudomonas pyrimidine salvage pathway
The salvage pathway, which varies from organism to organism, is responsible for
the recycling of pyrimidine bases, nucleosides and nucleotides.  The melting pot for
recycling is replenished primarily with mononucleotides from mRNA degradation.  The
salvage circuits are integral processes in all cells; in prototrophs salvage provides a
balance between RNA synthesis and the biosynthetic pathway, while supplying all the
necessary pyrimidine requirements in auxotrophs (O’Donovan & Shanley, 1995).  In P.
aeruginosa, the feeding of Pyr- mutants with exogenous uracil, uridine, cytosine or
cytidine satisfies the pyrimidine requirement.  Exogenous uracil is transported into the
cell by the uraA encoded enzyme, uracil permease, and is then converted to uridine 5'
monophosphate (UMP). This reaction is catalyzed by the enzyme uracil
phosphoribosyltransferase (UPRTase), encoded by the upp gene.  As in the biosynthetic
pathway described above, UMP is phosphorylated to UDP and thence to UTP, before
being converted to CTP by CTP synthetase (Fig. 2).  Cytosine is transported into the cell
by cytosine permease (codB), while the transport of exogenous uridine and cytidine into
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the cell occurs via uridine permease encoded by nup.  Once in the cell, all three of these
compounds are ultimately converted to uracil.  Cytosine is oxidatively deaminated to
uracil by cytosine deaminase encoded by codA, uridine is irreversibly hydrolyzed to
uracil and ribose by a non-specific nucleoside hydrolase encoded by nuh, and cytidine is
hydrolyzed to cytosine, which is then converted to uracil by cytosine deaminase.
Regulation of pyrimidine biosynthesis in Escherichia coli.
Prokaryotic organisms regulate their pyr genes by a variety of transcriptional and
translational attenuation mechanisms.  The pyrimidine biosynthetic pathway in E. coli is
regulated at the level of enzyme synthesis by attenuation (Roof et al., 1982; Turnbough et
al., 1983) and at the level of enzyme activity by allosteric inhibition (Gerhart & Pardee,
1962, 1964).  The pyrBI genes encoding ATCase and the pyrE gene specifying OPRTase
have upstream leader sequences that allow attenuation control.  In the case of the
extensively studied pyrBI, there are two promoters, P2 at -350 nucleotides and P1 at -160
nucleotides upstream from the translational start of pyrB.  Regardless of which promoter
is used, termination of the transcript occurs 40 bases upstream from the start of pyrB.
This rho-independent terminator region is high in G+C residues enabling the formation
of a stem-loop secondary structure.  This stem-loop is followed by a typical stretch of
uridine residues.  The mechanism of attenuation (Fig. 3) is such that when intracellular
UTP levels are high, the RNA polymerase transcribes the message through the stretch of
uridine residues thereby allowing the formation of the terminator loop.  The structural
genes are therefore not transcribed.  At low UTP levels, the RNA polymerase pauses at
10
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the stretch of uridine residues, this pause is long enough to allow the ribosome to catch
up to the RNA polymerase. Transcription and translation then become closely coupled
which prevents the terminator loop from forming and allows transcription of the pyrBI
operon (Navre & Schachman, 1983).
Control of enzyme activity occurs at three steps in the pyrimidine pathway.  In E.
coli, the first step is catalyzed by CPSase encoded by carAB, and is inhibited by UMP
and activated by ornithine and inosine-5’-monophosphate (IMP).  The second step is
catalyzed by ATCase, encoded by pyrBI, is inhibited by CTP and activated by ATP
(Foltermann et al., 1981).  The step catalyzed by pyrG encoded, CTP synthetase, is
inhibited by CTP and activated by UTP (Long & Pardee, 1967; Long & Koshland, 1978).
In Pseudomonas, the same three steps are strongly influenced by pyrimidine and purine
nucleotide effectors (Chu & West, 1990). CPSase enzyme activity is inhibited by UMP
and activated by ornithine and N-acetylornithine (Abdelal et al., 1983), while activity of
the pyrBC’ encoded ATCase is inhibited by ATP, CTP and UTP with ATP exerting the
greatest inhibition (Isaac & Holloway, 1968; Condon et al., 1976; Schurr et al., 1993;
Vickrey, 1993).
Regulation of the pyr operon in Bacillus subtilis.
In enteric bacteria, separate unlinked genes or operons encode the six-enzymatic steps of
pyrimidine biosynthesis, whereas in Bacillus these genes are arranged in an operon and
transcribed as a single message.  A novel mechanism for regulation of the pyr operon in
B. subtilis, proposed by Lu et al., (1995) describes transcriptional attenuation, controlled
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at three sites within the 5’ end of the pyr transcript, by a UMP-dependent RNA binding
protein encoded by the first gene of the operon, pyrR (Fig. 4).  At high pyrimidine
nucleotide levels, UMP binds to the PyrR protein forming a PyrR-UMP complex which
in turn binds to a specific sequence on the pyr mRNA.  This binding alters the secondary
structure of the pyr message and promotes the formation of a rho-independent terminator,
resulting in reduced expression of the pyrimidine genes that lie downstream from the
binding site (Lu et al., 1995, Lu & Switzer, 1996; Turner et al., 1998; Switzer et al.,
1999).  In addition, this regulatory protein, PyrR, has the catalytic salvage activity of
uracil phosphoribosyltransferase (UPRTase).
Regulation of pyrimidine biosynthesis in Pseudomonas aeruginosa.
Pyrimidine metabolism has not been extensively investigated in pseudomonads
and although previous studies have explored the regulation of pyrimidine biosynthesis
 (Isaac & Holloway, 1968; Condon et al., 1976), significant control at the level of gene
expression could not be substantiated. Unlike the pyr gene arrangement found in B.
subtilis, the pyrimidine genes in P. aeruginosa are scattered throughout the auxotrophic
portion of the chromosome (Fig. 5).
In this research study, the presence of the regulatory protein, PyrR, in P.
aeruginosa was identified and shown to regulate expression of the downstream
pyrimidine biosynthetic genes, pyrD, pyrE and pyrF as well as expression of the pyrR
gene.
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Fig.4.  Mechanism of attenuation control of the pyr operon in Bacillus subtilis.  Adapted































Fig. 5.  Arrangement of the pyrimidine genes on the P. aeruginosa chromosome.
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Catabolite repression control.
When an organism is supplied with two different carbon sources in its growth
medium, it generally utilizes them sequentially rather than simultaneously.  This
preference by an organism to utilize one carbon source over another in the presence of
both is known as catabolite repression control (CRC).  In E. coli and other Gram negative
enteric bacteria, glucose is the preferred carbon source and its catabolite repression
control involves the catabolite activator protein (CAP), also referred to as the cAMP
receptor protein (CRP) encoded by the crp gene.  In these enterics, transport of
glucose is driven by the phosphoenolpyruvate (PEP)-dependent transport system (PTS)
and the binding of the signal molecule, cyclic AMP (cAMP) to CAP.  This cascade
system induces adenylate cyclase activity, which in turn increases the intracellular cAMP
concentration.  In the presence of glucose, cAMP levels are low and the constitutively
expressed CAP is not bound by cAMP therefore does not activate transcription of the
repressed structural genes, e.g. lacZYA for lactose utilization.  However as the glucose
source is depleted, the intracellular levels of cAMP increase and the CAP-cAMP
complex forms which can bind to the promoter region of the repressed genes and enhance
transcriptional initiation.  Though the molecular mechanism of catabolite repression
control has been extensively characterized in E. coli and S. typhimurium, it is yet to be
fully characterized in P. aeruginosa.  Unlike the glucose effect on catabolite repression
found in E. coli, catabolite repression control of inducible catabolic pathways in
Pseudomonas does not appear to involve a cAMP-mediated mechanism (Siegel et al.,
1977; Philips & Mulfinger, 1981).  Acetate and tricarboxylic acid cycle intermediates,
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such as succinate have been shown to be the strongest repressing substrates in
Pseudomonas (Hylemon & Phibbs, Jr., 1972; Smyth & Clarke, 1975; Collier et al.,
1996).  So far, the only protein shown definitively to be involved in catabolite repression
control in P. aeruginosa, is the Crc protein (MacGregor et al., 1992).  Though its
function is yet to be identified, studies have recently shown that the Crc protein is
involved in the regulation of several pathways.  These include the expression of
branched-chain keto acid dehydrogenase (BCKAD) encoded by the bkd operon (Hester et
al., 2000a; 2000b), glucose-6-phosphate dehydrogenase (Wolff et al., 1991; Siegel et al.,
1977) and amidase (Smyth & Clarke, 1975; Farin & Clarke, 1978) in Pseudomonas.  The
recent studies by Hester et al. (2000a; 2000b) showed that the Crc protein affected
expression of BkdR, a positive transcriptional regulator of the bkd operon.  The
mechanism of action by Crc on BkdR is not known, however Phibbs and coworkers have
shown that the Crc protein has all the necessary structural features to cleave a
phosphodiester bond yet lacks the ability to bind DNA.  Therefore, it is thought that
perhaps the Crc protein, when activated, cleaves the mRNA at a specific site within the
secondary structure thereby affecting expression at the posttranscriptional level.  In P.
aeruginosa, the crc gene that encodes the Crc protein is located –80 bp upstream of the
pyrE gene, which encodes orotate phosphoribosyltransferase, and the two genes are
divergently transcribed (Fig. 6).  Divergent transcription is a relatively common type of
gene organization, approximately 40% of all transcription units in E. coli are transcribed
from divergent promoters (Opel et al., 2001).  Of these, approximately 60% contain one
or more operon or gene-specific regulatory genes.
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Fig. 6.  Partial nucleotide sequence of the P. aeruginosa pyrE and crc genes showing the 80 bp intergenic region
(MacGregor et al. (1996).
aagcgtccca ggcgggccag cgccaggccg ctgtcgaaca ggccggcatt gaagaaatag
gggctggtgc gcccggactt gagggtgaac tcaccgaagc gcagaacccc gcgctcgatg
gcgaaacgaa tgaaatcgcg ctgatacgcc tgcatgaatg acaccaagcc catgaattta
gctaaaccg tttgagctcg ggtatcatac acgcacgtga ttttgggggc catttatgcg
gatcatcagt gtgaacgtga atggtattca ggctgcggcc gagcgcggtt tgctcagttg








The purpose of this aspect of the research study is to explore any possible
involvement of Crc in pyrimidine metabolism in P. aeruginosa.
Dicarboxylate transport in Pseudomonas.
In Pseudomonas, the pyrimidine biosynthetic pathway is a six-step process
leading to UMP.  Of the pyrimidine biosynthetic pathway intermediates, it has been
shown in E. coli and S. typhimurium that orotate can satisfy the pyrimidine requirement
of pyr mutants, only when glycerol is used as the carbon and energy source (Baker et al.,
1996); glucose and orotate cannot satisfy this requirement.  It has also been reported that
a C4-dicarboxylate transport protein, DctA, encoded by the dctA gene is required in E.
coli and S. typhimurium since dctA mutants in these organisms are unable to utilize
succinate, malate or fumarate as sole carbon and energy sources.  In addition, succinate
was found to compete with orotate for entry into the enteric cell (Baker et al., 1996).
Therefore, the dctA gene product, in addition to transporting C4-dicarboxylates, mediates
the transport of orotate, a cyclic monocarboxylate.
The effect of succinate on the transport of orotate into the Pseudomonas cell was
investigated in the present study with the aim to identify in Pseudomonas the same
dicarboxylate transport system as seen in E. coli (Baker et al., 1996).
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MATERIALS AND METHODS
Bacterial strains, plasmids, media and growth conditions.
The bacterial strains and plasmids used in this study are listed in Tables 1a and
1b.  Bacteria were grown in Luria-Bertani (LB) enriched medium (Bertani, 1951),
Pseudomonas minimal medium supplemented with Hutner’s Metals 44 (Ornston &
Stanier, 1966) or in Escherichia  coli minimal medium (Miller, 1972).  For biparental
mating experiments, transconjugants were selected for on Pseudomonas isolation agar
(PIA, Difco).  Antibiotics were added at the following concentrations: ampicillin, 100 µg
ml-1; gentamicin, 20 µg ml-1; kanamycin 50 µg ml-1 for E. coli, and carbenicillin, 600 µg
ml-1, gentamicin, 100 µg ml-1, tetracyclin, 100 µg ml-1 for P. aeruginosa.  The carbon
sources used were glucose at 0.2% or succinate at 10 mM.  P. aeruginosa AK903 and
PAO1 wild type strains were employed throughout this study.  All E. coli and P.
aeruginosa strains were grown at 37°C with shaking at 250 rpm.
Preparation of competent cells.
All E. coli competent cells for transformation were prepared using the calcium
chloride method of Dagert & Ehrich (1979) with slight modifications.  The cultures were
grown in 50 ml LB medium to an optical density (OD) of 0.2 – 0.4 at 600 nm and chilled
on ice for 10 min.  The cells were harvested by centrifugation at 1875 g at 4°C for 15
min, the cell pellet was resuspended in 20 ml of ice-cold 0.1 M CaCl2 and incubated
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   Table 1a.  Bacterial strains used in this study.
Strains Description or relevant phenotype Source or reference
E. coli
DH5α ∆recA1 argF lacIZYA Bethesda Research Laboratory
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (KmR) De Lorenzo & Timmis (1994)
BL21 F- ompT gal dcm lon hsdSB (rB-mB-) Amersham Pharmacia Biotech.
JM109 recA1 endA1 gyrA96 hsdR17 supE44 relA1 ∆ (lac-proAB)
(F' traD36 proAB lacIq Z∆M15)
New England Biolabs, Inc.
P. aeruginosa
AK903 restriction minus derivative of PAO1; addition of casamino acids Potter & Loutit (1982)
PAO1 wild type Pseudomonas Stock Center
PAO8023 crc::CbR Pseudomonas Stock Center
PAO8020 crc::TcR Pseudomonas Stock Center
PAO8017 crc- pyrE- Pseudomonas Stock Center
PAO0114 pyrD Pseudomonas Stock Center
MVP7401 pyrR::GmR derivative of AK903 This study
MVP7402 out derivative of PAO1 This study
MVP7403 out derivative of PAO0114 This study
MVP7404 recruited strain derivative of PAO8017 This study
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   Table 1b.  Plasmids used in this study.
Plasmid Description or relevant phenotype Source or reference
pUC18 AmpR  lac∆ZM15 New England Biolabs
pUC41 11.8 kb insert containing the pyrRBC’ fragment in pUC18 Vickery (1993)
pCRII AmpR KanR  PCR cloning vector Invitrogen
pGmΩ1 bla aacC1; gentamicin cassette with omega loops on both ends Schweizer (1993)
pGEX-2T AmpR GST gene fusion vector Amersham Pharmacia Biotech.
pRTP1 AmpR  rpsL oriT cos Stibitz et al. (1986)
pQF50 AmpR promoterless - lacZ transcriptional fusion vector Farinha & Kropinski (1990a)
pQF52 AmpR promoterless - lacZ translational fusion vector Park et al. (1997)
pPZ352 PAO1 crc- MacGregor et al. (1991)
pMVP1 P. aeruginosa pyrR ; ~800 bp insert in pCRII (correct orientation) This study
pMVP2 P. aeruginosa pyrR ; ~800 bp insert in pCRII (wrong orientation) This study
pMVP3 pyrR::GmR in pMVP1, interrupted by a Gm cassette at a AatII site This study
pMVP4 ~2.3 kb pyrR::GmR fragment from pMVP3 in pRTP1 This study
pMVP5 P. aeruginosa upp; ~900 bp insert in pCRTMII (correct orientation) This study
pMVP6 P. aeruginosa upp; ~900 bp insert in pCRTMII (wrong orientation) This study
pMVP10 P. aeruginosa pyrR; ~510 bp insert in pGEX-2T This study
pMVP11 P. aeruginosa upp; ~600 bp insert in pGEX-2T This study
pMVP50 P. aeruginosa pyrR promoter region; ~320 bp insert in pQF50 This study
pMVP52 P. aeruginosa pyrR promoter region; ~310 bp insert in pQF52 This study
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on ice for 20-25 min.  The cells were centrifuged at 833 g at 4°C for 15 min, the pellet
was resuspended in 0.7 ml of ice-cold 0.1 M CaCl2 and incubated on ice overnight.  The
next day, glycerol was added to the cells at a concentration of 15%, the competent cells
were separated into 150 µl aliquots and stored at -80°C for up to 3 months.
Transformation of E. coli.
Transformations of E. coli were carried according to the method of Huff et al.,
(1990).  Approximately 40 ng of plasmid DNA was mixed with 150 µl of calcium
chloride prepared competent cells and the mixture were incubated on ice for 20 min. The
cells were then heat shocked at 42°C for exactly 2 min, 1 ml of LB was added to the cells
and incubated at 37°C for 1 h with shaking.  After 1 h, the cells were plated on LB
medium, and the transformed cells were selected for with the appropriate antibiotic.
Preparation of cell extracts for pyr assays.
P. aeruginosa PAO1 and its derivatives were grown in Pseudomonas minimal
medium in the presence of appropriate supplements.  The cultures (50 ml) were grown to
an OD of 0.6 at 600 nm, harvested and resuspended in 1 ml of 40 mM potassium
phosphate buffer (pH 7.0).  The cell suspension was ruptured by sonication.  The extract
was centrifuged at 12,000 g at 4°C for 5 min, and 300 µl of the supernatant was
withdrawn for assay of dihydroorotate dehydrogenase.  The remaining extract was
centrifuged at 12,000 g at 4°C for a further 25 min.  The supernatant (clarified extract)
was transferred to a sterile microcentrifuge tube for assay of the other pyrimidine
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enzymes. Protein concentration was determined by the method of Bradford (1976) with
bovine serum albumin as the standard (Fig. 7).
Aspartate transcarbamoylase (ATCase) assay.
 ATCase enzyme assays were performed using the method described by Gerhart
& Pardee (1962) with modification. The specific activity (µmol min-1 mg-1) was
determined by monitoring the enzymatic production of carbamoylaspartate (CAA) in 10
min at 37°C using the colorimetric method of Prescott & Jones (1969).  A 1 ml reaction
volume contained the following components: 40 µl of Tri-buffer, pH 9.5 (Ellis &
Morrison, 1982), (51 mM diethanolamine, 51 mM N-ethylmorpholine and 100 mM
MES), 50 µl of 100 mM potassium aspartate (pH 9.5), 100 µl of 50 mM
carbamoylphosphate (dilithium salt), 10 µl of clarified extract, 800 µl ddH2O.  In addition
to the reaction tubes, a control was also prepared by substituting the clarified extract for
ddH2O.  The ATCase assay tubes were prepared in advance, without the addition of
carbamoylphosphate, and preincubated at 37°C for 2 min.  The reaction was initiated by
the addition of carbamoylphosphate and the tubes were incubated at 37° for 10 min. After
10 min, the reaction was terminated by the addition of 1 ml of color mix (2 parts of 5 mg
ml-1 of antipyrine in 50% sulfuric acid (v/v) with 1 part of 8 mg ml-1 of 2, 3-butanedione
monoxime in 5% acetic acid (v/v)).  The reaction tubes were mixed by vortexing, and
incubated at 65°C for 2 h in the light to allow development of the color.  The tubes were
capped with marbles to minimize evaporation.  After 2 h, the absorbance at 466 nm was
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Fig. 7.  Bradford protein standard curve




















































measured, using the control tube to blank the spectrophotometer.  The mmoles of CAA
produced were determined using a CAA standard curve, prepared with known
concentration of CAA ranging from 0 to 450 nM in the standard assay reaction mix and
under the same color development conditions (Fig. 8).
Dihydroorotase (DHOase) assay.
The DHOase assay tubes contained the following components in a 1 ml reaction
volume: 100 µl of 1 M Tris (pH 8.6), 100 µl of 10 mM EDTA, 100 µl of 20 mM
dihydroorotate (in 0.1 M phosphate buffer, pH 7.5), 10 µl clarified extract and 690 µl of
ddH2O (Beckwith et al., 1962; Schwartz & Neuhard, 1975).  The DHOase assay tubes
were prepared in advance, without the dihydroorotate, and pre-incubated at 37°C for 2
min. The reaction was initiated by the addition of dihydroorotate and the tubes were
incubated at 37°C for 10 min. After 10 min, the reaction was terminated by the addition
of 1 ml of color mix as described for the ATCase assay.  The tubes were vortexed and
incubated at 65°C for 2 h in the light.  The absorbance was measured at 466 nm.  A
control tube containing all reaction components except dihydroorotate was used to blank
the spectrophotometer.
Dihydroorotate dehydrogenase assay.
Dihydroorotate dehydrogenase activity was measured spectrophotometrically by
monitoring the conversion of dihydroorotate to orotate at 290 nm.  The dihydroorotate
dehydrogenase reaction mix was prepared in a quartz cuvette containing the following
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components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 1 mM
dihydroorotate (in 0.1 M phosphate buffer, pH 7.5), 50 µl cell extract (from 5 min
centrifugation at 12 000 g) and ddH2O to a 1 ml total volume.  The reaction cuvette was
prepared in advance, without the dihydroorotate, and incubated at 37°C for 2 min. The
reaction was initiated with the addition of dihydroorotate, and the A290 units were noted
immediately, this was the blank reading.  The cuvette was then incubated at 37°C for 10
min, after which the A290 units were measured.  The blank reading was subtracted from
the 10 min reading.  An increase in absorbance of 1.93 is equivalent to a change in
substrate concentration of 1 mM (relative to the blank value, [Beckwith et al., 1962;
Schwartz & Neuhard, 1975]).
Orotate phosphoribosyltransferase (OPRTase) assay.
OPRTase activity was measured spectrophotometrically by the method of Smith
et al., (1980).  The conversion of orotate to OMP was monitored at 295 nm.  The
OPRTase reaction mix was prepared in a quartz cuvette containing the following
components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 0.25 mM
orotate, 0.6 mM 5-phosphoribosyl-1-pyrophosphate (PRPP), 50 µl clarified extract and
ddH2O to a 1 ml total volume.  The reaction cuvette was prepared in advance, without the
orotate, and incubated at 37°C for 2 min. The reaction was initiated with the addition of
orotate, and the A295 units were recorded immediately, this was the blank reading.  The
cuvette was then incubated at 37°C for 10 min, after which the A295 units were measured.
The 10 min reading was subtracted from the blank reading.  A decrease in absorbance of
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3.67 is equivalent to an increase in orotidine 5’-monophosphate (OMP) concentration of
1 mM (relative to the blank value, [Beckwith et al., 1962; Schwartz & Neuhard, 1975]).
OMP decarboxylase assay.
OMP decarboxylase activity was measured spectrophotometrically by monitoring
the conversion of OMP to uridine 5’-monophosphate (UMP) at 285 nm.  The OMP
decarboxylase reaction mix was prepared in a quartz cuvette containing the following
components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 0.2 mM OMP,
50 µl clarified extract and ddH2O to a 1 ml total volume.  The reaction cuvette was
prepared in advance, without the OMP, and incubated at 37°C for 2 min. The reaction
was initiated with the addition of OMP, and the A285 units were noted immediately, this
was the blank reading.  The cuvette was then incubated at 37°C for 10 min, after which
the A285 units were measured.  The 10 min reading was subtracted from the blank reading.
A decrease in absorbance of 1.38 is equivalent to a decrease in OMP concentration of 1
mM (relative to the blank value, [Beckwith et al., 1962; Schwartz & Neuhard, 1975]).
Cloning of the pyrR gene.
An 800 bp DNA fragment containing the pyrR gene was amplified from pUC41 plasmid
(Fig. 9., Vickrey, 1993) by the Polymerase Chain Reaction (PCR, Saiki et al., 1988) with
two synthetic oligonucleotides: oligo-1 (5’-TCCCATCGATGTCAGCGAGG-3’) and
oligo-2 (5’-GAGCAGCTCGCGGGGCAATC-3’).  The gene product was amplified
using Taq polymerase, which creates 3’-T overhangs, enabling direct ligation of the PCR
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Fig. 9.  Schematic diagram of pUC41 (Vickrey, 1993), derived from an EcoRI digest of
pUC18. The 11.8 kb insert contains the P. aeruginosa pyrRBC’ open reading frames
(ORF’s) taken from cosmid 011125 (obtained from B. W. Holloway).
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Fig. 10.  Schematic diagram of pCRII cloning vector (Invitrogen).  The multiple cloning
site is located within the disrupted lacZα gene to allow for blue/white selection, Kn
corresponds to kanamycin resistance gene and bla corresponds to the β-lactamase gene
which confers ampicillin resistance.
3.9 kb
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product into the pCRII vector from The Original TA Cloning Kit (Fig. 10., Invitrogen).
After transformation of E. coli DH5α, clones containing the pyrR insert were selected on
LB+kanamycin, with isopropyl-β-D-thiogalactopyranoside (IPTG) at 0.03% and 5-
bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) at 0.003%.  Restriction enzyme
digests determined the orientation of the pyrR inserts.  The resulting clone, pMVP1 (Fig.
11) had the pyrR gene inserted in the correct orientation and pMVP2 (Fig. 12) had the
pyrR gene inserted in the opposite orientation to the lac promoter on the vector.
DNA sequencing.
Sequencing of double-stranded DNA was performed with the Sequenase kit
(U.S. Biochemicals Corp.) based on the dideoxy method of Sanger et al., (1977).  All
reactions were carried out according to manufacturer’s specifications.  The
oligonucleotides used for the sequencing of the pyrR gene are listed in Table 2.
Table 2. Synthetic oligonucleotides used for sequencing.
Primer Sequence (5’-3’) Usage Supplier
pPA PE TTGGCGTCTGTCGGCAT Sequencing of pyrR gene Vickrey (1993)
PAR-1F CCATTATGCTTTCGCCACCG Sequencing of pyrR gene IDTa
PAR-1R TGCGCGGCAGGAGTTCGGCG Sequencing of pyrR gene IDTa
PAR-2R AGGGTCACGCTGGCCGGACG Sequencing of pyrR gene IDTa
PAR-3R CCTGGTCGTTGAGCTGCAGC Sequencing of pyrR gene IDTa
a IDT, Intergrated DNA Technologies, Coralville, IA.
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Fig. 11.  Construction of pMVP1 derived from pCRII vector (Invitrogen).  The resulting
4.7 kb plasmid includes an 800 bp fragment containing the P. aeruginosa pyrR gene,
cloned in the same orientation as the lac promoter.
4.7 kb
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Fig. 12.  Construction of pMVP2 derived from pCRII vector (Invitrogen).  The resulting
4.7 kb plasmid includes an 800 bp fragment, containing the P. aeruginosa pyrR gene




A 1.6-kb SmaI fragment containing the gentamicin resistance (Gm) cassette was
isolated from plasmid pGMΩ1 (Fig. 13., Schweizer, 1993) by digestion with SmaI and
agarose purification (Amersham Pharmacia Biotech.).  The Gm cassette was cloned into
the AatII located 178 bp into the pyrR gene on plasmid pMVP1.  The resulting plasmid,
pMVP3 (Fig. 14) was digested with NsiI to give a 2.4-kb fragment containing the
pyrR::Gm region. The fragment was agarose purified and the 5’-overhangs generated
from the NsiI digestion were “filled in” with T4 DNA polymerase.  This pyrR::Gm
fragment was cloned into the conjugation vector, pRTP1 ([digested with BamHI and
made blunt], Fig. 15., Stibitz et al., 1986) and the resulting gene replacement plasmid,
pMVP4 (Fig. 16), was transformed into E. coli SM10 (Simon et al., 1983) and used for
biparental mating with AK903.
Biparental mating experiment: pyrR cassette knockout into P. aeruginosa AK903.
The gene replacement plasmid, pMVP4, was mobilized into P. aeruginosa
AK903, by biparental mating as described by Gambello & Iglewski (1991).  Cells taken
from overnight cultures were used for the mating (Fig. 17), 1 ml of P. aeruginosa AK903
(recipient strain) cells grown at 37°C in LB were transferred to a sterile microcentrifuge
tube, centrifuged at 12,000 g for 1 min.  The supernatant was removed and 1 ml of E. coli
SM10 cell harboring the pyrR knockout plasmid (donor strain) grown in E. coli minimal
medium supplemented with 0.2% glycerol, 0.2% casamino acids, 1 mM MgSO4, and
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Fig. 13.  Schematic diagram of plasmid pGmΩ1 (Schweizer, 1993), containing the 1.6 kb
gentamicin resistant gene cassette for site-specific insertion and deletion mutagenesis.
The omega loops denote flanking regions containing the transcription and translation stop
signals of the Ω interposon, in inverted orientation.
pGmΩ1
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Fig. 14.  Construction of pMVP3, derived from pMVP1.  The resulting 6.3 kb plasmid
contains a 1.6 kb gentamicin (Gm) cassette fragment, digested from pGmΩ1 (Schweizer,
1993), cloned into the AatII restriction site of the pyrR gene.  Expression of the pyrR gene
is inactivated by the insertion of the Gm cassette.
6.3 kb
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Fig. 15.  Schematic diagram of the conjugation vector, pRTP1 (Stibitz et al., 1986). Sm
corresponds to streptomycin sensitivity and bla corresponds to β-lactamase conferring
ampicillin resistance.
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Fig. 16.  Construction of pMVP4, derived from pMVP3.  The ~2.4 kb NsiI  pyrR::Gm
fragment from pMVP3 was treated with T4 DNA polymerase and blunt end ligated into
the conjugation vector, pRTP1 digested with BamHI and blunt-ended (Stibitz et al.,





Fig. 17.  Diagrammatic representation of the biparental mating procedure.
Scrape cells and plate out dilutions
onto Pseudomonas Isolation Agar
(PIA) with gentamicin 100µg/ml
Plate bacterial mixture onto LB plate
and incubate 4-6 h at 37oC
Grown 18 hours in LB broth and mixed in
a 20:1 (recipient:donor)
Transformed into E. coli SM10
Pseudomonas aeruginosa AK903 grown
at 37oC
Screen for double-cross overs by replica patching onto
PIA gentamicin 100µg/ml and PIA carbenicillin 600µg/ml
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0.002% B1 (thiamine), was transferred to the same microcentrifuge tube and centrifuged
at 12,000 g for 1 min to pellet the cells.  The supernatant was removed and the cells were
vortexed, to thoroughly mix the recipient cells with the donor cells.  The mixed cells
were then plated onto LB medium that had been pre-warmed at 37°C, and then incubated
at 37°C for a further 4-6 h.  After incubation, 2 ml of sterile 1X PBS (pH 7.3) were added
to the plate, the cells were scraped using a sterile glass hockey stick and transferred into a
sterile 15 ml conical tube.  Serial dilutions of the cells were plated onto PIA+gentamicin
and incubated at 37°C overnight to select for single-crossover events.  The gentamicin
resistant colonies that appeared after overnight incubation were replica plated onto
PIA+gentamicin and PIA+carbenicillin to select for double-crossover events.  The
transconjugants that were gentamicin resistant (GmR) and carbenicillin sensitive (CbS)
had lost the vector sequence conferring the CbR allele, and had therefore undergone a
double crossover event.
Cloning of the upp gene.
A 940 bp DNA fragment containing the upp gene was amplified from P. aeruginosa
chromosomal DNA by PCR (Saiki et al., 1988) with two synthetic oligonucleotides:
oligo-1 (5’-TCGTTGTTGAACAGGCAGTC-3’) and oligo-2 (5’-
AAGGCGACGAACAGCATCT-3’).  The upp gene product was amplified using Taq
polymerase, which created 3’-T overhangs, enabling direct ligation of the PCR product
into the pCRII vector from The Original TA Cloning Kit (Fig. 10., Invitrogen).  After
transformation into E. coli DH5α, clones containing the upp insert were selected on
41
LB+kanamycin, with IPTG at 0.03% and X-gal at 0.003%.  Restriction enzyme digests
determined the orientation of the upp inserts.  The resulting clone, pMVP5 (Fig. 18) had
the upp gene inserted in the correct orientation and pMVP6 (Fig. 19) had the upp gene
inserted in the opposite orientation to the lac promoter on the vector.
RNA isolation.
The procedure for RNA preparation was essentially the same as that described by
Park et al. (1997).  P. aeruginosa PAO1 was grown in minimal medium to an OD600 of
0.4 - 0.5.  A 30 ml portion of the culture was transferred to a pre-chilled centrifuge tube,
and the chilled cultured was centrifuged at 30,000 g at 4°C for 15 min.  The cell pellet
was resuspended in 3 ml of a solution containing 0.02 M sodium acetate (pH 5.2), 1 mM
EDTA, and 0.2% diethylpyrocarbonate (DEPC), and then sodium dodecyl sulfate (SDS)
was added to a final concentration of 0.5% (w/v).  An equal volume of phenol was added
to the cell extract, vortexed for 30 s and then incubated at 65°C for 5 min with gentle
shaking. The mixture was then centrifuged at 30,000 g at room temperature for 15 min
and the aqueous phase (top layer) was transferred to a fresh conical tube.  An equal
volume of phenol:chloroform (1:1) was added, the mixture was vortexed briefly and
centrifuged at 30,000 g at room temperature for 15 min.  The aqueous phase was
transferred to a sterile, siliconized 25 ml Corex centrifuge tube, three volumes of ice-
cold 100% ethanol was added and the mixture was incubated at -80°C overnight (or 30
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Fig. 18.  Construction of pMVP5 derived from pCRII vector (Invitrogen).  The resulting
4.8 kb plasmid includes a 900 bp fragment containing the P. aeruginosa upp gene, cloned
in the same orientation as the lac promoter.
4.8 kb
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Fig. 19.  Construction of pMVP6 derived from pCRII vector (Invitrogen).  The resulting
4.8 kb plasmid includes a 900 bp fragment containing the P. aeruginosa upp gene, cloned
in the opposite orientation to the lac promoter.
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min if time was restricted).  The RNA precipitate was collected by centrifugation at
14,000 g at 4°C for 30 min, the RNA pellet was resuspended in 300 µl of DEPC-treated
TE buffer composed of 10 mM Tris and 1 mM EDTA (pH 8.0).  The RNA was extracted
three times with an equal volume of phenol, phenol:chloroform and then chloroform,
centrifuging at 12,000 g at 4°C for 15 min between each extraction.  The RNA was
precipitated with the addition of one tenth volume of 3M sodium acetate (pH 5.2), two
volumes of 100% ethanol and centrifuging at 12,000 g at 4°C for 15 min. The pellet was
washed with 1 ml of 70% ethanol followed by 90% ethanol and allowed to air dry. The
dried RNA pellet was resuspended in 100 µl of DEPC-treated water.  The RNA was
visualized by formaldehyde agarose gel electrophoresis (Fig. 20) and was quantified by
absorbance spectroscopy at 260 nm.
End labeling of nucleic acid probe.
End-lableled oligonucleotides were used for primer extension analysis and end-
labeled PCR products were used for gel mobility shift assays.  The end-labeling reaction
was prepared in a microcentrifuge tube and contained 120-150 ng of DNA, 50 µCi of γ-
32P-ATP, 1X polynucleotide kinase reaction buffer, 10 units of T4 polynucleotide kinase
in ddH2O (or DEPC treated ddH2O for probes to be used in primer extension analysis).
The reaction was incubated at 37°C for 1 h.  A 1 µl aloiquot of the reaction was
transferred to a sterile microcentrifuge tube for scintillation counts before purifying the
probe.  The unincorporated nucleoside triphosphates were removed from the remainder of
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Fig. 20.  Analysis of P. aeruginosa total RNA preparation by formaldehyde agarose gel
electrophoresis.  Lanes:  1, 8 µg RNA isolated from cells grown in Pseudomonas
minimal medium (Psmm);  2, 8 µg RNA isolated from cells grown in Psmm and 2 mM
uracil;  3, 10 µg RNA isolated from cells grown in Psmm and 1 mM orotate;  4, 10 µg
RNA isolated from cells grown in Psmm, 2 mM uracil and 1 mM orotate;  M, RNA
marker (Promega).













the reaction using a TE Micro SELECT-D, G-25 spin column (5 Prime → 3 Prime, Inc.).
The spin column was placed in a collection tube and centrifuged at 12,000 g for 20
seconds to remove the TE storage buffer.  The column was transferred to a fresh
collection tube, the labeling reaction was applied directly to the center of the gel
bed and allowed to sit undisturbed for 1 min and then centrifuged at 12,000 g for 20
seconds. The labeled nucleic acid was recovered in the collection tube in approximately
20 µl of TE buffer.  A 1 µl aliquot of the purified probe was transferred to a sterile
microcentrifuge tube and the counts per min (cpm) per microliter before and after column
purification were determined using a scintillation counter.  The percent of radioisotope
incorporated was calculated by dividing the cpm-after by the cpm-before and multiplying
by 100. According to manufacturer’s specifications, greater than 60% incorporation is
acceptable.
Primer hybridization and extension.
Primer extension analysis was used to identify the transcriptional start sites of
pyrR and pyrBC’.  The technique involves hybridizing a radiolabeled oligonucleotide
probe derived entirely from within the gene of interest, to complementary RNA, and
extending it using reverse transcriptase.  The hybridization reaction was prepared in a
PCR tube. Twenty micrograms of total RNA were mixed with 3 µl of freshly mixed 10X
hybridization buffer (0.2 M Tris, pH 8.0, 1 M NaCl, 1 mM EDTA) and 5 x 105 cpm of
radiolabeled primer.  DEPC-treated water was added to a final volume of 30 µl.  The
annealing reaction was performed between 95°C and 60°C with 3.5°C steps over 2 h in a
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thermal cycler. The salts were removed from the reaction mixture by ethanol
precipitation. The purified pellet was resuspended in 25 µl of reverse transcriptase
reaction mixture containing 3.5 µl of 4 mM dNTPs, 5 µl of 5X reverse transcriptase
reaction buffer, 1 µl of actinomycin D (1 mg ml-1), 50 units of RNasin, 10 units of AMV
reverse transcriptase in 13.25 µl of DEPC-treated ddH2O.  Actinomycin D was included
to prevent self-copying of the primer by reverse transcriptase. The hybridization and
extension reaction was performed at 42°C for 1 h and 30 min.  The extension reaction
was terminated by addition of EDTA at 20 mM and RNase at 0.4 mg ml-1 and further
incubated at 37°C for 30 min.  The DNA strand was recovered by two extractions with
phenol:chloroform, a chloroform extraction and ethanol precipitation. The nucleic acid
pellet was resuspended in 4 µl of ddH2O and 4 µl of sequencing loading dye (U.S.
Biochemicals Corp.), the sample was electrophoresed on a denaturing 4% acrylamide
7 M urea sequencing gel alongside a sequencing ladder from the same primer, and
visualized by autoradiography.
In vitro expression of PyrR.
The P. aeruginosa PyrR protein was expressed using an E. coli S30 Extract
System for Circular DNA (Promega) which simplifies the transcription/translation of
DNA sequences cloned into plasmid vectors.  This technique allows for the identification
and characterization of polypeptides based on the method described by Zubay (1973).
One microgram of pMVP1 plasmid DNA purified with the spin-midi kit (Bio 101) was
used as the DNA template and mixed with 5 µl of Amino Acid Mixture Minus
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Methionine, 20 µl of S30 Premix Without Amino Acids, 15 µCi of [35S] methionine
(NEN Dupont) and 15 µl of S30 Circular Extract.  Nuclease-free water was added to a
final volume of 50 µl, the components were mixed by gentle vortexing and then
centrifuged at 12,000 g for 5 s to bring the reaction mixture to the bottom of the tube.
The reaction was incubated at 37°C for 2 h and then terminated by placing the tube on ice
for 5 min.  A 5 µl aliquot of the reaction mixture was transferred to a fresh tube and
concentrated by acetone precipitation to remove the polyethyleneglycol (PEG) from the
extract.  To accomplish this, 20 µl of acetone was added to the 5 µl reaction mixture,
placed on ice for 15 min and centrifuged at 12,000 g at 4°C for 5 min.  The supernatant
was aspirated and the pellet was dried for 15 min under vacuum and resuspended in 10 µl
ddH2O.  The expressed protein was analyzed by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) and visualized by autoradiography.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE is a rapid method routinely used to quantify, compare and
characterize proteins.  This method denatures proteins into their individual subunits and
separates them based primarily on their molecular weights (Laemmli, 1970).  The SDS
binds along the polypeptide chain, masking the overall charge making the reduced SDS-
protein complex proportional to its molecular weight.  Samples were electrophoresed on
a 15% SDS polyacrylamide separating gel with a 5% stacking gel using a Mini-Protean II
electrophoresis apparatus (Bio-Rad).  The 15% separating gel was prepared by mixing 5
ml of acrylamide stock solution A (30% w/v acrylamide and 0.8% w/v N’N’-bis-
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methylene-acrylamide in ddH2O), 2.5 ml of denaturing solution B (1.5 M Tris-HCl, pH
8.8, 0.4% w/v SDS in ddH2O) and 2.5 ml of ddH2O.  Twenty milligrams of ammonium
persulfate was added and dissolved in the gel solution by gentle vortexing.  Just prior to
casting, 5 µl of N,N,N’,N’-tetramethylene-ethylenediamine (TEMED) was added, and
mixed into the solution by gentle inversion. The gel was cast immediately, leaving a 2 cm
gap at the top for the stacking gel.  N-butanol was layered above the gel to prevent drying
and to ensure a flat surface for the separating gel/stacking gel interface.  The gel was
allowed to polymerize at room temperature for 1 h.  After polymerization, the N-butanol
layer was washed off with ddH2O and the stacking gel was cast. The 5% stacking gel was
prepared by mixing 0.67 ml of solution A, 1 ml of denaturing solution C (0.5 M Tris-
HCl, pH 6.8. 0.4% w/v SDS), 2.3 ml of ddH2O, 10 mg of ammonium sulfate and finally 5
µl of TEMED.  Immediately after casting, the gel comb was inserted to form the loading
wells and the gel was allowed to polymerize at room temperature for 1 h.  The gel was
placed in a Mini Protean II electrophoresis tank and filled with denaturing electrophoresis
running buffer (25 mM Tris, 192 mM glycine and 0.1% w/v SDS, pH 8.3).  The samples
were prepared by mixing four parts of protein sample with 1 part of 5X SDS sample
buffer (60 mM Tris-HCl, pH 6.8, 25% glycerol v/v, 2% SDS w/v, 14.4 mM β-
mercaptoethanol, and 0.1% w/v bromophenol blue) in a sterile microcentrifuge tube.
Pre-stained broad range markers were used as standards (Bio-Rad). The samples and the
standards were boiled for 2 min, cooled, loaded onto the gel and electrophoresed for 1 h
15 min at 150 V.  The proteins were stained with Coomassie Blue staining solution (45%
methanol (v/v), 10% glacial acetic acid (v/v), 0.1% Coomassie Brilliant Blue R-250 (w/v)
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in ddH2O) for 20 min with gentle rocking. The gel was then rinsed with ddH2O and
destained with 10% methanol (v/v), 10% glacial acetic acid (v/v) in ddH2O overnight in a
sealed container.  The molecular masses of the proteins markers were: myosin, 209 kDa;
β-galactosidase, 124 kDa;  BSA, 80 kDa;  ovalbumin, 49.1 kDa,  carbonic anhydrase,
34.8 kDa,  soybean trypsin inhibitor, 28.9 kDa,  lysozyme, 20.6 kDa  and  aprotinin, 7.1
kDa.
Construction of the pyrR::lacZ transcriptional fusion.
A 320 bp DNA fragment incorporating the pyrR promoter region was amplified
from pUC41 (Vickrey, 1993) by PCR (Saiki et al., 1988) with two synthetic
oligonucleotides containing engineered enzyme restriction sites at the 5’ end: oligo-1 (5’-
CGCGGATCCAACGGCCGTTTCAACC-3’) has a BamHI site and oligo-2 (5’-
CCCAAGCTTGAGTTCGGCGGGATTG-3’) has a HindIII site.  The PCR product was
purified from an agarose gel, digested with BamHI and HindIII, and ligated into the
BamHI/HindIII sites of the broad-host-range lacZ transcriptional fusion vector, pQF50
(Farinha & Kropinski, 1990a) which contains a promoter-less lacZ gene (Fig. 21).  After
transformation into E. coli DH5α, lacZ-positive clones were selected on LB+ampicillin,
IPTG at 0.03% and X-gal at 0.003%.  The resultant plasmid, pMVP50 (Fig. 22), was
confirmed by restriction enzyme digests.
Construction of pyrR::lacZ translational fusion.
A 310 bp DNA fragment containing the pyrR translational start (MSLP) and
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Fig. 21.  Schematic diagram of the broad-host-range plasmid pQF50 (Farinha &
Kropinski, 1990a), which utilizes the promoterless lacZ gene derived from pCB267
(Schneider & Beck, 1986).  Two artificial trpA terminators are inserted in tandem




Fig. 22.  Construction of pMVP50, pyrR::lacZ transcriptional fusion, derived from
pQF50 (Farinha & Kropinski, 1990a).  A 300 bp fragment containing the P. aeruginosa
pyrR promoter region was inserted into the BamHI-HindIII sites of pQF50.
7.1 kb
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upstream promoter region was amplified from pUC41 (Vickrey, 1993) by PCR (Saiki et
al., 1988) with two synthetic oligonucleotides designed to generate HindIII and SmaI
restriction sites at the 5’ ends of oligo-1 and 2 respectively: oligo-1 (5’-
CCCCCCCAAGCTTAAC GGCCGTTTCAACCT-3’) and oligo-2 (5’-
TCCTCCTCCCCCGGGATTGGGTAGGCT CAT-3’).  The amplified PCR product was
agarose purified, digested with HindIII and SmaI and, ligated into HindIII-SmaI-cleaved
pQF52 (Fig. 23., Park et al., 1997).  After transformation into E. coli DH5α, the resultant
plasmid, pMVP52 (Fig. 24), was selected on LB+ampicillin, 0.3% IPTG and 0.003% X-
gal.
Electroporation.
The lacZ fusion plasmids were electroporated into P. aeruginosa by the method
of Farinha & Kropinski (1990b).  Logarithmically growing cells of OD600 ~0.5 were used
to make electrocompetent cells.  One milliliter of culture was centrifuged 12,000 g for 3-
5 min, the supernatant was discarded and the cells were washed with 1 ml of MOPS
buffer (1 mM of MOPS, 15% glycerol,v/v) for a total of 10 washes. After the final wash,
the cells were resuspended in 50 µl of MOPS buffer.  The 50 µl of electrocompetent cells
were mixed with ~500 ng of plasmid (1-5 µl) and pipetted into an electroporation cuvette
(0.1 cm gap).  The plasmid DNA was electroporated into the host cells using the Gene
Pulser II System (Bio-Rad), set at the following parameters: resistance at 400 Ω;
capacitance at 25 µF, and voltage at 2.5 kV.  After applying the electrical pulse, 1 ml of
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Fig. 23.  Schematic diagram of the lacZ translational fusion vector, pQF52 (Park et al.,
1997), derived from pQF50 (Farinha & Kropinski, 1990a).  The lacZ gene is cloned in
the opposite orientation to that of the bla gene to eliminate basal level expression of β-
galactosidase.
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 Fig. 24.  Construction of pMVP52, pyrR::lacZ translational fusion, derived from pQF52
(Park et al., 1997).  A ~310 bp fragment containing the P. aeruginosa pyrR promoter
region, Shine-Dalgarno sequence and the sequence of the first 4 amino acids of the pyrR
gene was inserted into the HindIII-SmaI sites of pQF52.
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LB broth was added to the cuvette and the cells were incubated at 37°C for 1 h with
shaking.  The cells harboring the fusion plasmid were selected on LB+carbenicillin.
β-Galactosidase assay.
β-galactosidase specific activity was determined by the method of Miller (1972).
Logarithmically (OD600 ~0.6) growing cultures were cooled by placing on ice for 20 min
to prevent further growth, and the OD600 was measured and recorded.  High level β-
galactosidase activity was assayed by adding 0.1 ml of the culture to 0.9 ml of Z buffer,
pH 7.0 (60 mM Na2HPO4⋅7H2O, 40 mM NaH2PO4⋅H2O, 10 mM KCl, 1 mM
MgSO4⋅7H2O, 50 mM β-mercaptoethanol).  The cells were lysed by the addition of 2
drops of chloroform, 1 drop of a 0.1% SDS solution, and vortexing for 10 seconds.  The
lysed cells were incubated at 28°C for 5 min.  The reaction was initiated by the addition
of 200 µl of o-nitrophenol-β-galactoside (ONPG)(4 mg ml-1 ONPG in Z buffer, pH 7.0),
and vortexed briefly.  The reaction tubes were assayed for 15 min at 28°C, and the color
reaction was stopped by the addition of 0.5 ml of 1 M Na2CO3. The A420 units were
measured using a control tube, containing all reaction components except cells, to blank
the spectrophotometer.  The A550 units were also measured to correct for light scattering
due to cell debris.  The specific activity of β-galactosidase was calculated as follows:
1000 x (A420 – 1.75 x A550)
t x v x OD600
where t = the time of the reaction (min), and v = the volume of culture per reaction (ml).
One unit of β-galactosidase hydrolyzes 1 nmol ONPG min-1 (mg protein)-1.
=  units of β-galactosidase
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Expression of pyrR.
A 510 bp DNA fragment of the intact  pyrR gene was amplified from pMVP1 by PCR
with two synthetic oligonucleotides designed to generate BamHI and EcoRI restriction
sites at the 5’ ends: oligo-1 (5’-CGCGGATTCCTACCCAATCCCGCC-3’) and oligo-2
(5’-CCGGAATTCAGGAAGCGGAGGAAAG-3’).  The PCR product was agarose
purified, digested with BamHI and EcoRI, and ligated into the BamHI/EcoRI sites of the
pGEX-2T gene fusion vector (Fig. 25., Amersham Pharmacia Biotech). The resulting
plasmid, pMVP10 (Fig. 26), was sequenced to confirm that the GST::PyrR fusion was
translated in-frame.  The pGEX-2T vector features a tac promoter for inducible, high-
level expression of fusion proteins with glutathione S-transferase (GST) (Smith &
Johnson, 1988).  The GST gene isolated from Schistosoma japonicum contains an ATG
start and ribosome-binding site.  The resulting fusion protein is be purified by affinity
chromatography using the GST purification system from Amersham Pharmacia Biotech.
Purification of the PyrR protein.
A culture of E.coli BL21 harboring pMVP10 was grown in LB+ampicillin (4
liters) to an OD600 ~ 0.8.  Fusion protein expression was induced with the addition of
IPTG at 0.1 mM.  The culture was incubated for an additonal 4 h at 37°C with shaking.
The cells were harvested by centrifugation at 10,000 g at 4°C for 45 min, and the cell
pellet was resuspended in 200 ml of cold phosphate buffered saline (1X PBS), containing
137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4.7H2O and 1.4 mM KH2PO4, pH 7.3.  The
cells were broken by passage through a French pressure cell (Aminco) at 20,000 lb psi.
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Fig. 25.  Schematic diagram of pGEX-2T, glutathione S-transferase fusion vector (Smith
& Johnson, 1988, Amersham Pharmacia Biotech.), an expression vector for inducible,





Fig. 26.  Construction of pMVP10 derived from pGEX-2T (Smith & Johnson, 1988;
Amersham Pharmacia Biotech.).  Plasmid pMVP10 has a ~510 bp fragment containing
an intact pyrR gene inserted into the BamHI-EcoRI sites of the expression vector, pGEX-




The crude extract was treated with DNase at 37 µg ml-1, Triton X-100 at 0.1%,
dithiothreitol (DTT) at 5 mM and incubated at 4°C overnight with gentle stirring.  The
crude extract was then centrifuged at 32,000 g for 30 min and the supernatant was
subjected to ammonium sulfate fractionation.  The fraction precipitating between 30 and
40% saturation was resuspended in 5 ml ice-cold 1X PBS, pH 7.3 and the lysate was
dialyzed against the same buffer at 4°C overnight.  The dialyzed solution was subjected
to affinity chromatography using the Pharmacia glutathione sepharose 4B matrix.  Batch
purification was carried out as specified by the manufacturer.  The GST:PyrR fusion
protein was eluted from the matrix two times with 2 ml of 10 mM reduced glutathione.
The eluted fractions that contained the GST:PyrR fusion were combined and dialyzed
against 1X PBS (pH 7.3) overnight at 4°C.  The dialyzed fusion sample was incubated
with 100 units of thrombin protease overnight at 4°C, to cleave the PyrR protein from the
GST tag.  The cleaved sample was subjected to anion-exchange chromatography. A
column was gravity packed with diethylaminoethyl (DEAE) Sepharose matrix (~ 1-2 ml
bed volume), and washed with at least 3 column volumes of 1X PBS (pH7.3).  The
sample was loaded onto the column and the flow through was collected. The column was
washed with 70 ml of 1X PBS (0 M NaCl fraction), and the GST tag eluted in this
fraction.  The column was again washed with 6 ml of 0.1 M NaCl to elute residual GST
tag and other contaminating proteins.  The PyrR protein was eluted with 3 ml of 0.2 M
NaCl.  All fractions were analyzed by SDS-15% PAGE.  The fraction containing purified
PyrR protein was dialyzed against PyrR buffer (100 mM Tris-acetate, pH 7.5, 10 mM
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potassium acetate, 20% glycerol) at 4°C overnight.  The purified protein (1 µg µl-1) was
separated into 100 µl aliquots, snap frozen in liquid nitrogen and stored at -80°C.
Expression of upp.
A 600 bp DNA fragment containing the intact  upp gene was amplified from
pMVP5 by PCR with two synthetic oligonucleotides designed to generate BamHI and
EcoRI restriction sites at the 5’ ends: oligo-1 (5’-GCGGATCCCCCGTACATGAGATC-
3’) and oligo-2 (5’-CCGGAATTCAGGCTTCCTTCTGCTT-3’).  The PCR product was
agarose purified, digested with BamHI and EcoRI, and ligated into the BamHI/EcoRI
sites of the pGEX-2T gene fusion vector (Fig. 25., Amersham Pharmacia Biotech). The
resulting plasmid, pMVP11 (Fig. 27), was sequenced to confirm that the GST-Upp fusion
was translated in-frame.
Purification of the Upp protein.
A culture of E.coli BL21 harboring pMVP11 was grown in LB+ampicillin (4 liters) to an
OD600 ~ 0.8, fusion protein expression was induced with IPTG at 0.1 mM and the cells
were incubated at 37°C with shaking for 4 h.  The cell lysate was prepared as described
previously for purification of the PyrR protein. The crude extract was subjected to
ammonium sulfate fractionation.  The fraction precipitating between 30 and 40%
saturation was resuspended in 5 ml ice-cold 1X PBS, pH 7.3 and the lysate was dialyzed
against the same buffer at 4°C overnight.  The GST-Upp fusion protein was purified by
affinity chromatography using the Pharmacia glutathione Sepharose 4B matrix.  Batch
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Fig. 27.  Construction of pMVP11 derived from pGEX-2T (Smith & Johnson, 1988;
Amersham Pharmacia Biotech.).  Plasmid pMVP11 has a 600 bp fragment containing an
intact upp gene inserted into the BamHI-EcoRI sites of the expression vector, pGEX-2T.




purification was carried out according to manufacturer’s specifications.  The GST-Upp
fusion protein was eluted from the matrix two times with 2 ml of 10 mM reduced
glutathione.  The eluted fractions containing the GST-Upp fusion were combined and
dialyzed against 1X PBS (pH 7.3) overnight at 4°C.  The dialyzed fusion sample was
incubated with 100 units of thrombin protease overnight at 4°C, to cleave the PyrR
protein from the GST tag. The fraction containing purified Upp protein was dialyzed
against PyrR buffer (100 mM Tris-acetate, pH 7.5, 10 mM potassium acetate, 20%
glycerol) at 4°C overnight.  The purified protein was separated into 100 µl aliquots, snap
frozen in liquid nitrogen and stored at -80°C.
Isolation of DNA fragments for electrophoretic mobility shift assays (EMSA).
DNA fragments containing the promoter regions of the pyrR (327 bp), pyrD (254
bp), pyrE (255 bp) and pyrF (175 bp) genes were amplified from P. aeruginosa
chromosomal DNA by PCR (Fig. 28).  The oligonucleotides used are listed in Table 3.
The PCR products were agarose purified and end-labeled with γ-32P using polynucleotide
kinase as described earlier.  These radiolabeled PCR fragments were used as DNA probes
for EMSA.
Electrophoretic mobility shift assays (EMSA).
EMSA is a sensitive method for the detection of specific in vitro interactions of
DNA and/or RNA with proteins (Ausubel et al., 1993), and is also commonly referred to
as gel retardation or gel shift assays. Interactions between proteins and target DNA or
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Fig. 28.  Agarose gel electrophoresis analysis of PCR fragments used for EMSA assays.
Lanes:  1, 1 kb DNA marker (New England Biolabs);  2, fragment of the pyrR upstream
region (327 bp);  3, fragment of the upp upstream region (280 bp);  4, fragment of the
pyrD upstream region (254 bp);  5, fragment of the pyrE upstream region (255 bp);  6,
fragment of the pyrF upstream region (175 bp).
Table 3. Synthetic oligonucleotides used to generate DNA probes for EMSA
Primer Sequence (5’→ 3’) Usage Suppliera
PQF50-RF CGCGGATCCAACGGCCGTTTCAACC PCR of pyrR probe IDT
PQF50-RR CCCAAGCTTGAGTTCGGCGGGATTG PCR of pyrR probe IDT
PyrD-Forward CGGCAGGGCCAATCGGGTCCTGCT PCR of pyrD probe Bio-synthesis
PyrD-Reverse CAGTTTGAACAGCAGCTGGCGGGC PCR of pyrD probe Bio-synthesis
PADPYRE-F GCCGTCCAGTTGGAAGGACGGGTCA PCR of pyrE probe IDT
PADPYRE-R CGCGCTGATACGCCTGCATGAATGA PCR of pyrE probe IDT
PyrF-Forward GTCGACTGGCTGGAGCAACTGCTC PCR of pyrF probe Bio-synthesis
PyrF-Reverse AATCCAGGGCGACGATGATGGGGG PCR of pyrF probe Bio-synthesis




    kbp                1      2       3       4      5      6
2.0
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RNA, results in the formation of a protein-DNA/RNA complex.  This protein-DNA/RNA
complex would migrate at a slower rate through a non-denaturing polyacrylamide gel,
due to a measurable decrease or shift in mobility when compared to unbound DNA or
RNA.  Electrophoretic mobility shift assays for RNA binding were performed by Heather
Savacool-Bonner of Robert L. Switzer’s Research Group, University of Illinois, Urbana,
IL.  The assays were carried out according to the method of Turner et al. (1998).  The gel
shift assay for DNA binding was performed using the method described by Proctor
(1998) with slight modifications. A 4% non-denaturing polyacrylamide stock solution
composed of 50 ml of 40% (19:1) acrylamide:bis-acrylamide, 25 ml of 5X Tris-Borate-
EDTA (TBE) buffer, pH 8.0 in 500 ml of ddH2O was prepared.  The 5X TBE buffer
contained 0.5 M Tris-HCl  (pH 8.0), 0.5 M Boric acid and 5 mM EDTA.  The 4%
polyacrylamide stock solution was purified through a 0.45 µm porosity filter (Millipore)
and stored at 4°C for up to 3 months.  The gel was prepared by the addition 0.02 g of
ammonium persulfate and 10 µl of TEMED to 10 ml of 4% polyacrylamide stock
solution.  The gel was pre-electrophoresed in 0.25X TBE buffer, pH 8.0 at 4°C for 45
min prior to loading the binding reactions.  The following solutions required for the
binding reaction were prepared;
10X Gel shift binding buffer – filter sterilized through a 0.4 µm porosity filter
0.25 M Tris-HCl, pH 8.0
0.06 M MgCl2





0.2 volume 10X gel shift binding buffer
0.1 volume 5 mM DTT
γ-32P-ATP labeled DNA probe to ~50,000 cpm/10 µl of 2X cocktail.
Adjust volume to 1.0 ml with sterile ddH2O.
1X Dilution buffer - store at -20°C
100 µl 10X gel shift binding buffer
100 µl 5 mM DTT
100 µl 1 mg ml-1 bovine serum albumin (BSA)
700 µl sterile ddH2O
The binding reactions were prepared in a volume of 20 µl and contained the following
components: 5-9 µl of 1X dilution buffer, 10µl of 2X probe cocktail, and 1-5 µg of
purified protein.  When required, the following ligands were added to the binding
reaction at 0.1 mM; orotate, orotidine 5’-monophosphate (OMP), uridine 5’-
monophosphate (UMP) and 5-phosphoribosyl-1-pyrophosphate (PRPP).  The final
volume of each binding reaction was adjusted to 20 µl and incubated at room temperature
for 30 min. After incubation, 10 µl of the binding reaction were loaded onto a pre-
electrophoresed 4% non-denaturing polyacrylamide gel, and the bound and unbound
DNA was separated at 100 V for 30-40 min.  The gel was transferred to 3 mm Whatman
filter paper and dried under vacuum at 75°C for 2 h.  The results were visualized by
autoradiography.
The apparent dissociation constants (Kd) of PyrR for the target DNA/or ligands
were determined by varying the concentration of PyrR (0.1 µg to 5 µg) used in the
binding reaction.  The concentration of radiolabeled DNA/or ligands was held constant
and the density of the bands was measured using a NIH Image Version 1.61 densitometry
program by Wayne Rasband.
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The competitive ligand binding assays were performed by varying the
concentration of one ligand in the binding reaction (0.03 mM to 1 mM), and keeping the
concentration of the second ligand constant at 0.1 mM.
High performance liquid chromatography (HPLC) gel filtration.
HPLC-gel filtration was used to determine the native size of the PyrR protein.
The following molecular weight protein standards were loaded onto a Protein Pak Steel
300SW (7.5 mm x 30 cm) gel filtration column (Waters Corp.) at a concentration of 15
µg: blue dextran , 2,000 kDa;  apoferritin, 443 kDa;  β-amylase, 200 kDa;  alcohol
dehydrogenase, 150 kDa;  and  carbonic anhydrase, 29 kDa (Sigma-Aldrich Co.).  The
mobile phase was 50 mM Tris-acetate, pH 7.5 (Turner et al., 1998), which had been
filtered through a 0.4 µm filter (Millipore) and degassed by vacuum and sonication.  The
flow rate was 1 ml min-1 and the detection wavelength was 214 nm and 280 nm.  A
standard curve of retention time versus molecular weight was generated.  Seven
micrograms of purified PyrR protein was loaded onto the column.  The purified PyrR
protein was loaded onto the column under the following conditions: 7 µg of PyrR alone,
7 µg of PyrR, 6 mM MgCl2 and 0.2 mM PRPP pre-incubated at room temperature for 10
min, 7 µg of PyrR, 6 mM MgCl2 and 2 mM PRPP pre-incubated at room temperature for
10 min and, 7 µg of PyrR, 6 mM MgCl2 and 2 mM OMP pre-incubated at room
temperature for 10 min.  The native size of PyrR under the varying conditions was
determined directly from the standard curve.  The reaction in the presence of 2 mM PRPP
was repeated using 50 µg of PyrR and 1 ml fractions were collected.  The protein in each
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fraction was concentrated by trichloroacetic acid (TCA) precipitation and analyzed on
15% SDS-PAGE, to confirm the presence of the PyrR subunit (Bollag & Edelstein,
1991).
HPLC-enzyme assays.
Enzyme activities were assayed using the reverse-phase SUPELCOSIL-LC-18-T
column, 4.6 mm x 15 cm, (Supelco), which features a special surface treatment along
with an octadecylsilane bonding for efficient separation of nucleotides.  The mobile
phase was a 0.1 M phosphate buffer, pH 5.3 prepared by mixing 86.6 ml of 1 M KH2PO4
and 13.2 ml of 1 M K2HPO4, bringing the volume up to 950 ml with ddH2O and adjusting
to pH 6.0 with 1 M KOH.  An ion pairing agent, tetrabutylammonium hydrogen sulfate
was added to a final concentration of 10 mM, which caused a drop in to pH 5.3, the final
volume was then adjusted to 1 liter with ddH2O.  The buffer solution was filtered through
a 0.4 µm filter and degassed under vacuum with sonication.  The flow rate was 1.5 ml
min-1, and the nucleotides were detected at wavelengths 254 nm and 280 nm (Beck, 1995;
Turner et al., 1998).
HPLC-Uracil phosphoribosyltransferase (UPRTase) assay.
The UPRTase reaction mix contained 50 mM Tris, 6 mM MgCl2, 0.6 mM PRPP,
0.5 mM uracil, and either 20 µl of clarified extract or 10 µg of purified PyrR protein, in a
reaction volume of 250 µl at a final pH 8.0.  The reaction was initiated with the addition
of uracil.  Reactions with clarified extract were assayed for 10 min and reactions with
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purified PyrR protein were assayed for 30 min.  The reactions were terminated by the
addition of an equal volume of 0.5 M perchloric acid, which denatured the proteins.  The
pH was adjusted to pH 7.0 by the addition of 20 µl of 1 M KOH. The tubes were
incubated on ice for 5 min, and centrifuged at 12,000 g for 5 min to pellet the precipitate.
The supernatant was filtered through a 0.4 µm filter and 50 µl was loaded onto the
column (Beckwith et al., 1962; Beck. 1995).
HPLC-Orotate phosphoribosyltransferase (OPRTase) assay.
The OPRTase reaction mix contained 50 mM Tris , 6 mM MgCl2, 0.6 mM PRPP, 0.5
mM orotate, and either 20 µl of clarified extract or 10 µg of purified PyrR protein, in a
reaction volume of 250 µl at a final pH 8.0.  The reaction was initiated with the addition
of orotate.  Reactions with clarified extract were assayed for 10 min and reactions with
purified PyrR protein were assayed for 30 min.  The reactions were terminated by the
addition of an equal volume of 0.5 M perchloric acid, which denatured the proteins.  The
pH was adjusted to 7.0 by the addition of 20 µl of 1 M KOH. The tubes were incubated
on ice for 5 min, and centrifuged at 12,000 g for 5 min to pellet the precipitate.  The
supernatant was filtered through a 0.4 µm filter and 50 µl was loaded onto the column.
HPLC-Orotate decarboxylase assay.
The orotate decarboxylase reaction mix contained 50 mM Tris (pH 8.0), 0.5 mM
orotate, and 20 µl of clarified extract in a reaction volume of 250 µl.  The reaction was
initiated with the addition of orotate and was assayed for 20 min.  The reactions were
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terminated by the addition of an equal volume of 0.5 M perchloric acid, which denatures
the proteins.  The pH was adjusted to 7.0 by the addition of 20 µl of 1 M KOH. The tubes
were incubated on ice for 5 min, and centrifuged at 12,000 g for 5 min to pellet the
precipitate.  The supernatant was filtered through a 0.4 µm filter and 50 µl was loaded
onto the column.
Amino-terminal amino acid sequencing.
Edman degradation of the PyrR protein was kindly performed at the Molecular
Genetics Facility of Georgia State University by Dr. John Houghton.  The purified PyrR
protein was separated by SDS-PAGE and then electroblotted onto a polyvinylidene
difluoride (PVDF) membrane.  The amino-terminal amino acid sequence was determined
with a Beckman LF3200 gas-phase protein sequenator.
Western blotting.
Bacillus subtilis PyrR polyclonal antibodies, kindly supplied by Dr. Robert L.
Switzer, University of Illinois, were used to show crossreactivity with the P. aeruginosa
PyrR protein.  Ten micrograms of purified PyrR protein was electrophoresed on a SDS-
15% polyacrylamide gel as previously described.  The gel was placed onto a 0.45µm pure
nitrocellulose membrane and sandwiched with a piece of 3 mm Whatman filter paper and
a Fiberpad sponge on each side. The nitrocellulose membrane, filter paper, and sponges
were pre-soaked in cold transfer buffer (50 mM Tris (pH 7.5), 380 mM glycine, 0.1%
SDS (w/v), and 20% methanol (v/v) in ddH2O).  The gel sandwich was placed in a Mini
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Trans-Blot Electrophoretic Transfer Cell (Bio-Rad) with the gel positioned on the
cathode side of the system.  The protein was electroblotted onto nitrocellulose membrane
at 45 V overnight at 4°C.  The membrane containing transferred protein was incubated in
100 ml of blocking buffer (3% BSA w/v, 0.1% Tween 20 v/v, in TBS buffer, pH 7.5) at
room temperature with gentle rocking for 2 h.  The TBS buffer was prepared with 10 mM
Tris-HCl, pH 7.5, 150 mM NaCl in ddH2O.  The membrane was then sealed in a
hybridization bag with 25 ml of a solution containing the primary antibody, anti-B.
subtilis PyrR, diluted 1:1000 in TBS buffer, and incubated at room temperature with
gentle rocking for 1 h.  The membrane was then washed with 100 ml of TNT buffer
(0.1% BSA w/v, 0.1% Tween 20 v/v in TBS buffer, pH 7.5) for 15 min with gentle
rocking at room temperature.  The wash was repeated 3 times for a total of 4 washes at 15
min intervals.  The membrane was then placed in a hybridization bag and incubated with
25 ml of a solution that contained the secondary antibody, anti-rabbit IgG alkaline
phosphatase conjugate (Sigma-Aldrich Co.), diluted 1:3000 in TBS buffer, pH 7.5.  The
membrane was incubated with secondary antibody for 1 h at room temperature with
gentle rocking.  The membrane was washed 4 times with 100 ml of TNT buffer, changing
the buffer every 15 min.  During the washes, the following light sensitive solutions were
prepared in amber flasks: 5-bromo-4-chloro-indoyl-phosphate/ nitroblutetrazolium
detection reagent (BCIP/NBT, one tablet dissolved in 30 ml ddH2O) and 20 ml stop
buffer (20 mM EDTA in TBS buffer).  After the washes, the membrane was incubated in
the detection solution with gentle rocking, until the color developed and bands were
visible.  The reaction was terminated by the addition of stop solution.
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Effect of carbon source on orotate utilization.   
A 50 ml culture of the P. aeruginosa pyrD auxotroph (PAO0114) was grown in
Pseudomonas minimal medium with glucose (0.2%) as the carbon source, and uracil (50
µg ml-1) as the pyrimidine source.  The optical density at 600 nm was measured.  A 1 ml
aliquot of the overnight culture was harvested, washed twice with 5 ml of 1X PBS (pH
7.3) and resuspended in 1 ml of the same buffer.  A 100 µl aliquot of the washed cells
was used as inoculum for subculturing.  The strain was tested for its ability to use either
uracil at 50 µg ml-1 or orotate at 50 µg ml-1 to satisfy the pyrimidine requirement.  The
experiment was repeated using 10 mM succinate as the carbon and energy source.
Effect of varying concentrations of succinate on orotate utilization.   
Two 5 ml cultures of the P. aeruginosa pyrD auxotroph (PAO0114) were grown
overnight in Pseudomonas minimal medium.  One tube was grown with glucose as the
carbon and energy source and uracil as the pyrimidine source at 50 µg ml-1.  The other
tube was grown with succinate as the carbon source and uracil as the pyrimidine source at
50 µg ml-1.  The optical density at 600 nm was measured, a 1 ml aliquot was harvested,
washed twice with 5 ml of 1X PBS (pH 7.3) and resuspended in an appropriate volume of
the same buffer to yield the same concentration of cells in both tubes.  Two sets of
Pseudomonas minimal broth tubes were prepared with the following succinate
concentrations: 2 mM, 5 mM, 10 mM and 20 mM.  One set of tubes was inoculated with
100 µl of washed cells grown in glucose and the other set was inoculated with 100 µl of
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washed cells grown in succinate.  Cultures were incubated at 37°C with shaking for two
days, and the optical density at 600 nm measured.
5’-Fluoroorotate plate assays.
P. aeruginosa wild type (AK903) and crc mutant (PAO8023) strains used for this
assay were grown overnight in Pseudomonas minimal medium with the appropriate
carbon source and supplemented with casamino acids (0.2%), uracil (50 µg ml-1) and
carbenicillin (600 µg ml-1) when required.  A 100 µl aliquot of overnight culture was
plated onto Pseudomonas minimal medium supplemented with the appropriate carbon
source and the necessary supplements.  Immediately after plating, a pre-determined
amount of 5'-fluoroorotate (FOA) crystals were placed in the center of the plate.
Whenever a quantitative assay was required, a sterile filter disk saturated in a 1 mg ml-1
solution of FOA was placed in the center of the plate.  All plates were incubated at 37°C
overnight.  Growth up to the crystal or disk was indicative of resistance to FOA while a
zone of killing was indicative of sensitivity to FOA.
Competitive entry assay: radiolabeled orotate versus succinate
P. aeruginosa wild type (AK903) and crc mutant (PAO8023) strains were grown
overnight in Pseudomonas minimal medium with glucose as the carbon and energy
source and the appropriate antibiotic.  The cells were harvested at 1875 g for 15 min,
washed three times in 5 ml of 1X PBS (pH 7.3) and resuspended in 4.5 ml of the same
buffer.  The optical density at 600 nm was measured and the volume of the remaining
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culture was adjusted with 1X PBS to yield the same concentration of cells in each tube.
One milliliter of each culture was added to three separate microcentrifuge tubes, each
containing 1 µCi of 3H radiolabeled orotate.  The tubes were incubated at room
temperature for 30 min.  The cells were vacuum filtered through a 0.45 µm nitrocellulose
membrane, washed twice with 3 ml of 1X PBS and allowed to air dry overnight.  The
membrane filters containing the dry cells were placed in scintillation vials with 8 ml of
scintillation fluid, and counts per min (cpm) were measured using a scintillation counter.
The cpm of 1 µCi of 3H-orotic acid was measured as a control.  The percent of
radiolabeled orotic acid that entered the cells was calculated as follows:
cpm sample
cpm of 1 µCi of 3H-orotic acid
Isolation of out mutants.
Mutants defective in orotate utilization (out mutants) were isolated on glucose
minimal medium based on their resistance to the analog 5-fluoroorotate.  P. aeruginosa
PAO1 was grown overnight in glucose minimal medium.  One hundred microliters of this
overnight culture were plated onto glucose minimal medium and a pre-determined
amount of 5-fluoroorotate crystals were placed in the center of the plates as described
above.  The P. aeruginosa pyrD auxotroph (PAO0114) was also grown in glucose
minimal medium supplemented with cytosine (0.1mM) as pyrimidine source.  A 100 µl
aliquot of this culture was plated onto glucose minimal medium supplemented with
cytosine (0.1 mM).  Pre-determined amounts of 5-fluoroorotate crystals were placed in
x 100  =  % orotic acid uptake
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the center of the plates.  All plates were incubated at 37°C for two days.  After two days
of incubation, the colonies that appeared within the zone of killing were taken to be out
mutants as these mutants have been shown in E. coli by Baker et al., (1996) to be mapped
at the out locus.
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RESULTS AND DISCUSSION
Sequencing of the pyrR gene.
 In light of the prevalence of pyrR genes in several different organisms (Ghim &
Neuhard, 1994; Li et al., 1995; Elagöz et al., 1996) the nucleotide sequence of the region
upstream of the Pseudomonas aeruginosa  pyrBC’ operon, encoding ATCase, was
determined using pUC41 plasmid DNA as the template (Fig. 29).  Computer analysis of
this sequence revealed an open reading frame (ORF) of 510 nucleotides that encoded a
polypeptide of 170 amino acids, with a deduced molecular mass of 19 kDa and a
calculated isoelectric point of 5.2. Using the BLAST algorithm (Sonnhammer & Durbin,
1994; Altschul et al., 1990), this 510 bp ORF was searched against protein sequences in
the GenBank database.  Results revealed that the P. aeruginosa PyrR protein showed
greatest similarity (87%) and identity (77%) with that of the P. putida PyrR protein
(Kumar, 2000).  In addition, the next closest match was found to be with the pyrR gene of
Thermus aquaticus (Van de Casteele, 1997) at 63% similarity and 45% identity.
Primer extension analysis
To identify the transcription-initiation site for the pyrR transcript, a primer
extension assay was performed using an end-labeled oligonucleotide primer.  Total RNA
samples were isolated from wild type P. aeruginosa grown under four different





ATG AGC CTA CCC AAT CCC GCC GAA CTC CTG CCG CGC ATG GCC AGC GAC CTG CGC
 M   S   L   P   N   P   A   E   L   L   P   R   M   A   S   D   L   R
GCC CAT CTC GCC GAG CGC GGC ATC GAG CGG CCG CGC TTC GTC GGC ATC CAT ACC
 A   H   L   A   E   R   G   I   E   R   P   R   F   V   G   I   H   T
GGC GGC ATC TGG GTC GCC GAG GCG CTG CTG AGG GAA CTG GGC AAC CAA GAG CCG
 G   G   I   W   V   A   E   A   L   L   R   E   L   G   N   Q   E   P
CTG GGC ACC CTC GAC GTC TCC TTC TAC CGC GAC GAC TTC ACC CAG AAC GGC CTG
 L   G   T   L   D   V   S   F   Y   R   D   D   F   T   Q   N   G   L
CAT CCG CAG GTC CGC CCG TCG GCG CTG CCG TTC GAG ATC GAC GGC CAG CAC CTG
 H   P   Q   V   R   P   S   A   L   P   F   E   I   D   G   Q   H   L
GTG CTG GTG GAC GAC GTG CTG ATG AGC GGC CGT ACC ATC CGC GCC GCA CTC AAC
 V   L   V   D   D   V   L   M   S   G   R   T   I   R   A   A   L   N
GAA CTG TTC GAC TAC GGC CGT CCG GCC AGC GTG ACC CTG GTC TGC CTG CTC GAC
 E   L   F   D   Y   G   R   P   A   S   V   T   L   V   C   L   L   D
CTG AAC GCC CGG GAG TTG CCT ATC CGC CCC GAC GTG GTC GGC CAG ACC CTG TCC
 L   N   A   R   E   L   P   I   R   P   D   V   V   G   Q   T   L   S
CTG GGT CGC GAT GAA CGG GTA AAA TTG GTC GGT CCC GCA CCG CTC GCC CTC GAG
 L   G   R   D   E   R   V   K   L   V   G   P   A   P   L  L   E
CGC AAG GTC CTT TCC TCC GCT TCC TGA TCCTCTTCACTAGGGCCTGCCCC
 R   K   V   L   S   S   A   S   *      
GAC GCC AAG CGC CCG CTG CAG CTC AAC GAC CAG GGC CAG CTG CGC
TCG CTC GAC GGA TTG CCC CGC GAG CTG CTC ACC GAA ATC CTC GAT
TCC TTC CTG GAG GTC GGC GCC
Fig. 29.  Nucleotide sequence of the 517 bp DNA fragment bearing the co
aeruginosa pyrR gene and partial pyrB gene.  The transcriptional start site
35 sequences and the ribosomal binding site (RBS) are indicated in color.
amino acid sequence of the ORF is shown, the stop and start codons are in
and green, respectively.  The asterisk indicates the pyrR stop codon. The u
denote the 23 bp gap between the end of the pyrR gene and the start of the  A  
pyrB
 ATG CCG ACA
  M   P   T
 CAC TTC ATC
 ACC GCC GAT
mplete P.
 (+1), -10 and -





orotate and (iv) uracil and orotate.  Results are shown in Fig. 30.  A major extension
product that corresponded to a transcription-start site (+1 position) situated 67
nucleotides upstream of the translational start codon was detected.  As can be seen from
Figure 29, the transcription-start was located appropriately downstream of putative –10
and –35 sequences.  This promoter region contained elements typical of an activatable
Pseudomonas σ70 consensus (Fig. 31., Deretic et al., 1989; Ronald et al., 1992) and,
when subjected to computer analysis, revealed the formation of a putative stem-loop
secondary structure encompassing the Shine-Dalgarno sequence and the AUG start codon
(Fig. 32).  Such secondary structure formation is typical of an autogenous mechanism of
regulation (McCarthy & Gualerzi, 1990; Ohta et al., 2001), suggesting that pyrR encoded
a protein that regulated its own expression.  To find out if the putative pyrR promoter
region were active, a 320 bp DNA fragment that contained the –10 and –35 sequences
within the upstream region was fused to a promoter-less lacZ gene, pMVP50, and
assayed for β-galactosidase activity.  Results showed that the lacZ gene was expressed in
wild type P. aeruginosa (Table. 4), confirming the presence of an active promoter located
upstream of the pyrR gene.  In addition, this confirmed the direction of transcription of
pyrR was the same as that of the pyrBC’ operon and the intergenic gap between pyrR and
pyrBC’ being only 23 bp, confirmed that pyrR was the first gene of a tricistronic operon
pyrRBC'.
Sequence comparison with other known PyrR proteins.
Using a CLUSTAL W version 6.0 computer program (Higgins et al., 1996), a
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Fig. 30.  Autoradiogram of primer extension analysis to determine the transcription
initiation site of the P. aeruginosa pyrR gene.  Lane 1 corresponds to total RNA isolated
from wild type P. aeruginosa grown without the addition of supplements and lane 2, 3
and 4 correspond to total RNA isolated from wild type P. aeruginosa supplemented with
2 mM uracil (lane 2), 1 mM orotate (lane 3), 2 mM uracil and 1 mM orotate (lane 4).
DNA sequencing termination reactions for G, A, T and C are marked.  The sequence of
the antisense strand is shown along the side and the arrow indicates the extended primer.












A   Pseudomonas rpoD promoter consensus
Gene   -35 No. of   -10 No. of +1
        nucleotides    nucleotides
oprI CGCTTGGTC 16 AAGTAATGG 16 C
argF TCCTTGTGT 17 TTATAAGAT - -
catBC ATATTGGAC 17 GCGCAATCC 10 A
nahR     TATTGATA 17 ATATAATAA 6 A
algR2 GTCTTGATG 16 GCATAATCT 9 C
hutH GCTTTGGAT 17 TGATACTGA - -
Consensus  YSTTGR 17-18  YRTAAT
pyrR TGGCAGCC 18  CATTAT 10 C
B   Pseudomonas activatable rpoD promoter consensus
               -35                       -10
nenA         ATTGACAAATAAAAAGCACGCTCAC--CATCATCGCGAA
nenG         TTTATCAATATTGTTTGCTCCGT----TATCGTTATAAC
corG         ATTGGACGGCTATCAGGGTCTCGCGC-AATCCTTGAACA
crcA         CATGACACGCGAATCTTAGCATT----CATGTTTGAAGC
xylDEG       TATCTCTAGAAAGGCCTACCCCT----TAGGCTTTATGC
pyrR       CATGGCAGCCGGCACGCCGCCGTTTGCCATTATGCTTTC
Fig. 31.  Pseudomonas promoter sequences.  Figure adapted from Deretic et al, (1989) and Ronald et al., (1992).
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Fig. 32.  RNA secondary structure of P. aeruginosa pyrR transcript starting with the first
residue of the mRNA using the Rna Viz secondary structure computer program (De Rijk
& De Wachter, 1997).
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Table 4. β-galactosidase activity measurements of pyrR::lacZ reporter gene fusions in P.
aeruginosa wild type, AK903 and pyrR mutant strain, MVP7401 under different
conditions of growth.







pyrR::lacZ AK903 Wild type 330.5 330.2 319.8 353.3
pyrR::lacZ MVP7401 pyrR - 816.7 695.5 899.5 850.1
a One unit of β-galactosidase hydrolyzes 1 nmol of o-nitrophenol per min-1 mg of protein-1.










































Multiple alignment was performed to compare the P. aeruginosa PyrR with other known
PyrR proteins (Fig. 34).  P. aeruginosa PyrR displayed significant sequence homology to
all other PyrR proteins sharing greatest homology with that of P. putida.  In B. subtilis, a
seven residue sequence, RGHRELP, has been shown to form a loop that is necessary for
the dimerization of the PyrR protein (Tomchick et al., 1998).  This folding conformation
has been shown to be essential for the PyrR protein to bind RNA.  Such a conserved
stretch of amino acid residues was not present in the P. aeruginosa sequence, suggesting
that the Pseudomonas PyrR protein was not likely to be a RNA binding protein.  The
conserved regions in the flexible loop and the central phosphoribosylpyrophosphate
(PRPP) binding domain have been shown to bind to the co-regulator molecule PRPP
(Fig. 34., Tomchick et al., 1998).  In B. subtilis, it has been shown that bound PRPP
antagonizes the binding effect of PyrR.  Both of these regions are also conserved in the
Pseudomonas PyrR proteins, suggesting that a similar mechanism of action by PRPP is in
play.  Also in B. subtilis, the residues NGK, which form the trimer loop, are necessary for
the shifting between the dimeric and hexameric forms, were absent in the P. aeruginosa
PyrR sequence.  This suggested that a dimeric to hexameric shift may not occur in the P.
aeruginosa PyrR protein. At the N-terminus of PyrR for both P. aeruginosa and P.
putida, there was a stretch of 10 hydrophobic amino acids that are not present in other
PyrR sequences (Fig. 35) therefore this hydrophobic region is a candidate for the
dimerization domain in the Pseudomonas PyrR proteins.  Towards the C-terminus of the
P. aeruginosa PyrR there is a stretch of 41 amino acids that has 100% identity with that
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Fig. 34.  Aligned amino acid sequences of PyrR proteins from various organisms. Key
amino acid residues are denoted by the following symbols: R (♦); E (♣); T (•); V (Φ); K
(∆). Bacterial genomes currently being sequenced: The Institute for Genomic Research
(TIGR); Bacillus anthracis Ames, Dehalococcoides ethenogenes, Enterococcus faecalis
V583, Geobacter sulfurreducens, Mycobacterium tuberculosis H37Rv, Mycobacterium
avium 104, Staphylococcus aureus COL, Streptococcus pneumoniae type 4, and
Thiobacillus ferridoxin ATCC 23270. The Sanger Centre (S.C.); Clostridium difficile 630
(epidemic type X), Corynebacterium diphtheriae NCTC 13129, Streptomyces coelicolor
A3(2). Genome Therapeutics Corporation (GTC); Clostridium acetobutylicum ATCC
824D. Joint Genome Institute (JGI); Enterococcus faecium ATCC 35667, Nitrosomonas
europeae, Nostoc punctiforme, Prochlorococcus marinus MED 4. University of
Oklahoma Advanced Center for Genome Technology (OU-ACGT); Actinobacillus
actinomycetemcomitans HK1651, Bacillus stearothermophilus 10, Streptococcus
pyogenes SF370 (MI), Streptococcus mutans UAB159. Integrated Genomics Inc. (IGI);
E. faecium ATCC 35667. Kazusa DNA Research Institute & Michigan State University;
Anabaena SP PCC7120. London School of Hygiene and Tropical Medicine (LSHTM),
Imperial College & Eastman Dental Institute; Clostridium difficile 630 (epidemic type
X). Public Health Lab Service (PHLS), Degussa AG & Bielefeld University;
Corynebacterium diphtheriae NCTC 13129. University of Minnesota; Pasteurella
multocida Pm70. University of Washington; Haemophilus ducreyi 35000 HP. John Innes
Centre; Streptomyces coelicolor A3(2). University of Massachusetts at Amherst and
Exxon Corporation; Geobacter sulferreducens. Completed sequences: Bacillus subtilis
(Quinn et al., 1991), Bacillus caldolyticus (Ghim & Neuhard, 1994), Deinococcus
radiodurans (White et al., 1999), Haemophilus influenzae (Fleischmann et al., 1995),
Lactobacillus plantarum (Elagöz et al., 1996), Lactococcus lactis (Bolotin et al., 1999),
Synechocystis sp. PCC6803 (Kaneko et al., 1996), and Thermus aquaticus Z05 (Van de
Casteele et al., 1997).   
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Fig. 35.  Alignment of the P. aeruginosa and P. putida PyrR protein sequences with the B. subtilis sequence.
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of P. putida (Fig. 35).  Most of these 41 amino acids were unique to the Pseudomonas
PyrR sequences.
In vitro transcription and translation analysis.
The P. aeruginosa pyrR gene on a ~800 bp DNA fragment was cloned into the
expression vector pCRII (Fig. 10., Invitrogen) in the same orientation to that of the lac
promoter, to create pMVP1 (Fig. 11).  The same ~800 bp DNA fragment which
contained the 510 bp pyrR gene was also cloned in an orientation opposite to the lac
promoter on the pCRII vector to create pMVP2 (Fig. 12).  To determine if the P.
aeruginosa pyrR gene encoded a protein product, an in vitro transcription/translation
(Zubay, 1973) was performed using plasmid pMVP1, with pMVP2 as a negative control.
Based on gene sequence, the theoretical molecular mass of this PyrR protein was deduced
to be 19 kDa.  However on a SDS-PAGE gel, the 510 bp pyrR gene encoded a protein
that electrophoresed at 24 kDa (Fig. 36).  Such differences between actual and theoretical
weights could be explained by the effect of charge on the mobility of small proteins in
SDS-PAGE (Swank & Munkres, 1971; Merle & Kadenbach, 1980).  The in vitro
transcription/translation sample was also analyzed under non-denaturing conditions, the
native PyrR protein migrated to a locus between the 66 kDa and 132 kDa molecular
weight markers.  Based on a monomer of 19 kDa, this most likely corresponded to a
tetramer with an apparent molecular mass of ~80 kDa (Fig. 37).
An in vitro transcription/translation analysis was also performed using plasmid
pMVP5 (Fig. 18) to determine the apparent molecular mass of the P. aeruginosa Upp
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Fig. 36.  Autoradiogram of SDS-12% PAGE from in vitro transcription and translation
analysis (Zubay, 1973) to determine apparent subunit size of the PyrR protein from P.
aeruginosa.  Lanes:  1, expression of the pyrR gene cloned in the same orientation as the
lac promoter on the vector (pMVP1);  2, expression of the pyrR gene cloned in an
orientation opposite to the lac promoter, (pMVP2, control).  The molecular masses of the









1            2 kDa
91
Fig. 37.  Autoradiogram of native-10% PAGE from in vitro transcription and translation
analysis (Zubay, 1973) to determine apparent native size of the PyrR protein from P.
aeruginosa.  Lanes:  1, expression of the pyrR gene cloned in an orientation opposite to
the lac promoter on the vector (pMVP2, control);  2, expression of the pyrR gene cloned
in the same orientation as the lac promoter, (pMVP1).  The molecular masses of the
protein markers are shown alongside.





Fig. 38.  Autoradiogram of SDS-12% PAGE from in vitro transcription and translation
analysis (Zubay, 1973) to determine apparent subunit size of the Upp protein from P.
aeruginosa.  Lanes:  1, expression of the upp gene cloned in the same orientation as the
lac promoter on the vector (pMVP5);  2, expression of the upp gene cloned in an
orientation opposite to the lac promoter, (pMVP6, control).  The molecular masses of the
protein markers are shown alongside.
120.0







protein. Plasmid pMVP6 (Fig. 19) containing the upp gene cloned in an orientation
opposite to the lac promoter was used as a negative control.  Results showed that the Upp
protein electrophoresed at approximately 28 kDa (Fig. 38).
Insertional inactivation of pyrR by cassette mutagenesis.
To determine the effect of PyrR on the expression of pyrimidine genes, the pyrR
gene on the P. aeruginosa chromosome was inactivated by gene replacement, using a
gentamicin cassette.  Mating experiments were performed and a P. aeruginosa pyrR
deletion strain, MVP7401 was isolated.  The pyrimidine enzymes encoded by pyrB,
pyrC, pyrD, pyrE and pyrF were assayed in P. aeruginosa AK903 and in the isogenic
pyrR mutant strain, MVP7401.  Results seen in Table 5 showed that inactivation of the
pyrR gene caused approximately a two-fold decrease in expression of the pyrBC’, pyrD
and pyrE genes, and about a three-fold decrease in the expression of pyrF compared to
expression of these genes in the isogenic wild type strain.  Expression of pyrC was the
least affected, being reduced only 20% by inactivation of pyrR.  The decrease in
expression of the pyr genes suggested that PyrR was a positive regulator of the
expression of the downstream pyrimidine biosynthetic genes.  The role of PyrR as an
activator is unique to Pseudomonas, as the well characterized PyrR protein from B.
subtilis is a mRNA-binding attenuation protein.  Interestingly, a polar effect was
observed for expression of the pyrBC’ genes, since inactivation of the pyrR gene did not
completely diminish pyrBC’ expression.  Primer extension and complementation studies
in P. putida showed the presence of a second transcription-start site located about 67-69
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bp upstream of the pyrBC’ translational start and a putative promoter region that resulted
in the extension of a minor transcript. In addition, a P. putida pyrR mutant harboring the
pyrR gene on a plasmid restored parental gene expression levels in all except the pyrBC’
genes (Kumar, 2000).  The low ATCase activity observed in the P. aeruginosa pyrR
mutant suggested the presence of two promoters governing expression of the P.
aeruginosa pyrRBC’ operon. The stronger P1 promoter located 67 bp upstream of the
PyrR translational start generates the major transcript as a single pyrRBC’ message while
the minor pyrBC’ transcript is generated from the second P2 promoter located upstream
of the pyrBC’ genes (Fig. 39).
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Table 5. Specific activities of the pyrimidine biosynthetic enzymes in P. aeruginosa wild
type and pyrR mutant.
Specific Activity






Aspartate transcarbamoylase (pyrB) 107.8 40.3
Dihydroorotase (pyrC) 152.3 126.4
Dihydroorotate dehydrogenase (pyrD) 32.0 16.3
Orotate phosphoribosyltransferase (pyrE) 22.8 12.5
OMP decarboxylase (pyrF) 18.4 6.6
E. coli constitutive promoter consensus
          -35         -10
   TTGACA           TATAAT 
  5 - 21 bases
    PAO1 pyrBC'    TGTCGC------------------TAAAAT
Fig. 39.  Pseudomonas pyrBC’ promoter (P2) sequence.
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Autoregulation by PyrR.
Computer analysis of the pyrR promoter region revealed a potential RNA
secondary structure formation suggestive of autoregulation (Fig. 32).  To determine if
PyrR is under autogenous control, the DNA upstream of the pyrR coding sequence was
cloned into the reporter gene vector, pQF50.  The resulting pyrR::lacZ transcriptional
fusion plasmid, pMVP50 was electroporated into P. aeruginosa pyrR mutant strain,
MVP7401 and assayed for β-galactosidase activity against its isogenic wild type strain as
described in Materials and Methods.  Results indicated an upto three-fold increase in β-
galactosidase activity in the pyrR mutant strain compared to the wild type strain (Table.
4, Fig. 33).  In the absence of the PyrR protein there was a higher level of pyrR
expression, with PyrR negatively regulating its own expression.  The scattered
distribution of the pyr genes throughout the genome suggested that the P. aeruginosa
PyrR was more likely to be a DNA binding protein.  The approximate location of these
pyr genes in the P. aeruginosa genome are pyrBC’ (20'), pyrC (35'), pyrC3 (74’), pyrD
(40'), pyrE (9') and pyrF (50').  The pyr genes in B. subtilis are arranged in an operon and
expressed from a single message, a situation more conducive to regulation by an RNA
binding protein.  Results from the above pyrR::lacZ transcriptional fusion assay
suggested that PyrR binds DNA.  The decrease in β-galactosidase expression, seen in the




To prove the PyrR proteins ability to bind DNA, the protein was purified by
classic chromatographic methods, for testing both autoregulation and DNA binding to the
downstream pyr genes.  For affinity chromatography, the P. aeruginosa pyrR was fused
to the glutathione S-transferase (GST) gene from Schistosoma japonicum, and cloned into
the expression vector pGEX-2T which has a thrombin protease recognition site for
cleaving the PyrR protein from the fusion product.  The resulting plasmid, pMVP10, was
sequenced to ensure in frame translation of PyrR from the GST protein tag.  Sequence
data showed that PyrR was translated in frame as a fusion from the GST protein, and that
the first methionine codon of the PyrR protein was replaced with a glycine residue.  The
plasmid pMVP10 was transformed in E. coli BL21, a protease deficient host strain
commonly used for high-level expression of recombinant proteins (Studier & Moffatt,
1986), and expression of the fusion protein was induced with IPTG.  To determine the
IPTG concentration at which optimal expression could be achieved, 50 ml cultures of E.
coli BL21 harboring pMVP10 were induced with IPTG varying from 0.1 mM to 0.9 mM,
and analyzed by SDS-PAGE (Fig. 40).  Results showed that 0.1 mM IPTG was sufficient
for maximal expression of the GST protein, since the intensity of the band which
corresponded to the GST protein did not increase at IPTG concentrations greater than 0.1
mM.  An induction time course study was performed to determine the length of time that
allowed for maximum yield of the fusion protein.  A 50 ml culture of E. coli BL21
harboring pGEX-2T was induced with 0.1 mM IPTG and 1 ml aliquots were removed at
1 h intervals for up to 6 h, and the samples were analyzed by SDS-PAGE (Fig. 41).
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Fig. 40.  SDS-12% PAGE analysis of samples obtained from the induction study to
determine optimum IPTG concentration for expression of pMVP10 in E. coli BL21.  All
inductions were performed for 4 h.  Lanes:  1, molecular mass marker (myosin, 205 kDa;
β-galactosidase, 120 kDa;  bovine serum albumin, 84 kDa;  ovalbumin, 52.2 kDa;
carbonic anhydrase, 36.3 kDa;  and soybean trypsin inhibitor, 30.2 kDa);  2,  0.1 mM
IPTG;  3, 0.2 mM IPTG;  4, 0.3 mM IPTG;  5, 0.4 mM IPTG;  6, 0.5 mM IPTG;  7, 0.6
mM IPTG;  8, 0.7 mM IPTG;  9, 0.8 mM IPTG;  10, 0.9 mM IPTG.









Results showed that an induction time of 4 h was sufficient for optimal expression of the
GST::PyrR fusion protein.  All subsequent cultures for protein expression were therefore
induced with 0.1 mM IPTG for 4 h.  Most of the contaminating cellular proteins were
removed from the clarified lysate by ammonium sulfate fractionation.  A step gradient
fractionation was performed to determine the percent saturation at which the fusion
protein was precipitated (Fig. 42), most of the GST::PyrR fusion precipitated between 30
and 40% saturation.  These two fractions were pooled and used for batch purification
using glutathione Sepharose 4B as the affinity matrix.  SDS-PAGE analysis of the
fractions obtained throughout the affinity chromatography purification procedure is
shown in Fig. 43.  Eluates 1, 2 and 3 shown in lanes 8, 9 and 10 respectively contained
the GST::PyrR fusion, however these fractions also contained contaminating proteins.
This indicated that some non-specific proteins bound to the glutathione Sepharose 4B
matrix. Anion exchange chromatography was employed to remove these contaminating
proteins, however before further purification, the eluate fractions were pooled and treated
with thrombin protease to cleave PyrR from the GST tag.  To determine the optimal
cleavage time with thrombin, a time course study was performed.  A 200 µl aliquot of the
GST::PyrR fusion was incubated with 50 units of thrombin protease at 4°C, and 20 µl
samples were removed at 1 h intervals for up to 8 h and analyzed by SDS-PAGE (Fig.
44).  Results showed that an 8 h incubation did not allow for complete cleavage.  Based
on this information, a cleavage time of ~16 h (overnight) was adopted for the purification
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Fig. 41.  SDS-12% PAGE analysis of samples obtained from the time-course IPTG
induction study.  The cells were induced with 0.1 mM IPTG.  Lanes:  1, molecular mass
marker (myosin, 202 kDa;  β-galactosidase, 109 kDa;  bovine serum albumin, 78 kDa;
ovalbumin, 46.7 kDa;  carbonic anhydrase, 34.5 kDa;  and soybean trypsin inhibitor, 28.8
kDa);  2,  uninduced cells (0 h);  3, 1 h induction;  4, 2 h induction;  5, 3 h induction;  6, 4
h induction;  7, 5 h induction;  8, 6 h induction.
GST








Fig. 42.  SDS-12% PAGE analysis of samples obtained from the ammonium sulfate
fractionation of pMVP10 expressed in E. coli BL21.  Lanes:  1, molecular mass marker
(myosin, 205 kDa;  β-galactosidase, 120 kDa;  bovine serum albumin, 84 kDa;
ovalbumin, 52.2 kDa;  carbonic anhydrase, 36.3 kDa; and soybean trypsin inhibitor, 30.2
kDa);  2, 20% saturation;  3, 25% saturation;  4, 30% saturation;  5, 35% saturation;  6,
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Fig. 43.  SDS-12% PAGE analysis of the fractions collected during affinity
chromatography purification of P. aeruginosa PyrR.  Washes were with 5 ml of 1X PBS,
pH 7.3 and fusion protein was eluted with 2 ml of 10 mM reduced glutathione.  Lanes:  1,
molecular mass marker (bovine serum albumin, 84 kDa;  ovalbumin, 52.2 kDa;  carbonic
anhydrase, 36.3 kDa;  soybean trypsin inhibitor, 30.2 kDa;  and lysozyme, 21.9 kDa);  2,
flow through;  3, wash 1;  4, wash 2;  5, wash 3;  6, wash 4;  7, wash 5;  8, eluate 1;  9,
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Fig. 44.  SDS-12% PAGE of samples obtained from time course cleavage of P.
aeruginosa PyrR from the GST tag.  The fusion protein was incubated with 50 units of
thrombin protease.  Lanes:  1, molecular mass standards (β-galactosidase, 124 kDa;
bovine serum albumin, 80 kDa;  ovalbumin, 49.1 kDa;  carbonic anhydrase, 34.8 kDa;
soybean trypsin inhibitor, 28.9 kDa;  and lysozyme, 20.6 kDa);  2, uncleaved sample (0 h
incubation with thrombin);  3, after 1 h incubation;  4, after 2 h incubation;  5, after 3 h
incubation;  6, after 4 h incubation;  7, after 5 h incubation;  8, after 6 h incubation;  9,
after 7 h incubation;  10, after 8 h incubation.  Proteins were visualized by Coomassie
blue staining.











procedure.  The thrombin treated fraction was subjected to anion-exchange
chromatography on DEAE Sepharose for the next step in the purification.  Results from
Figure 45 showed that the bulk of the GST protein eluted in the 0 M NaCl (lane 1), the
0.1 M NaCl fraction contained most of the uncleaved GST::PyrR fusion, the remainder of
the GST and about 50% of the PyrR protein.  The remainder of the PyrR protein eluted
with 0.2 M NaCl however this fraction also contained small amounts of the GST and
fusion proteins.
Western blot analysis.
To establish that the purified protein which corresponded to an apparent
molecular mass of 21 kDa was the P. aeruginosa PyrR protein, a Western blot analysis
was performed with polyclonal antibodies raised against the B. subtilis PyrR protein
(kindly provided by Dr. R. L. Switzer, University of Illinois).  These antibodies cross-
reacted with crude extract from wild type P. aeruginosa (data not shown), with pure PyrR
protein and with the GST::PyrR fusion protein from P. aeruginosa (Fig. 46), which
suggested that these two proteins bore similar antigenic epitopes.  The same antibodies
did not react with the negative control, E. coli JM109 crude extract.
Purification of the Upp protein.
Prior to the affinity chromatography step, the majority of the contaminating cellular
proteins from the clarified lysate were removed by ammonium sulfate fractionation.  A
step gradient fractionation was performed to determine the percent saturation at which the   
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Fig. 45.  SDS-15% PAGE analysis of the fractions collected during the DEAE anion
exchange chromatography purification of P. aeruginosa PyrR.  Lanes:  1, molecular mass
marker (β-galactosidase, 120 kDa;  bovine serum albumin, 84 kDa;  ovalbumin, 52.2
kDa;  carbonic anhydrase, 36.3 kDa;  soybean trypsin inhibitor, 30.2 kDa;  and lysozyme,
21.9 kDa);  2, 0 M NaCl elution;  3, 0.1 M NaCl elution;  4, 0.2 M NaCl elution.  The
proteins were visualized by Coomassie Blue staining.











Fig. 46.  Western blot with antibodies raised against PyrR from Bacillus subtilis.  PyrR
antiserum (1:1000) was probed against 10 µg of total protein.  Lanes:  1, molecular mass
marker (β-galactosidase, 120 kDa;  bovine serum albumin, 84 kDa;  ovalbumin, 52.2
kDa;  carbonic anhydrase, 36.3 kDa;  soybean trypsin inhibitor, 30.2 kDa;  and lysozyme,
21.9 kDa;  aprotinin, 7.4 kDa);  2, purified P. aeruginosa PyrR;  3, wild type B. subtilis
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GST-Upp fusion protein precipitated (Fig. 47), most of the GST-Upp fusion appeared to
precipitate between 20 and 40% saturation.  These three fractions were pooled and used
for batch purification using glutathione Sepharose 4B as the affinity matrix.  The eluate
which contained the GST-Upp fusion protein was cleaved with thrombin protease, and
the cleaved sample was subjected to a second round of batch purification to remove the
GST tag.  SDS-PAGE analysis (Fig. 48) showed that affinity chromatography sufficiently
removed all contaminating proteins leaving only purified Upp protein.
RNA-binding electrophoretic mobility shift assay (EMSA).
Switzer and co-workers have shown using a RNA-binding EMSA that the B.
subtilis PyrR protein binds to the pyr mRNA.  To determine if the P. aeruginosa could be
an RNA-binding protein, a RNA-binding EMSA using purified P. aeruginosa PyrR
protein with mRNA isolated from B. subtilis was performed by Heather Savacool-Bonner
of Dr. R.L. Switzer’s research group, University of Illinois (data not shown).  The results
showed that the P. aeruginosa PyrR did not bind to the pyr mRNA from B. subtilis,
suggesting that it was not likely to be a RNA-binding protein since all other RNA-
binding PyrR proteins have the conserved residues shown by Switzer and co-workers be
involved in binding RNA.
DNA-binding EMSA.
Data from pyr enzyme assays in a pyrR cassette deletion mutant, PyrR sequence
analysis and data obtained from pyrR::lacZ transcriptional fusion assays all
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Fig. 47.  SDS-12% PAGE analysis of samples obtained from the ammonium sulfate
fractionation of pMVP11 expressed in E. coli BL21.  Lanes:  1, molecular mass marker
(myosin, 205 kDa;  β-galactosidase, 120 kDa;  bovine serum albumin, 84 kDa;
ovalbumin, 52.2 kDa;  carbonic anhydrase, 36.3 kDa; and soybean trypsin inhibitor, 30.2
kDa;  lysozyme, 21.9 kDa);  2, 20% saturation;  3, 25% saturation;  4, 30% saturation;  5,
40% saturation;  6, 50% saturation.
GST-Upp









Fig. 48.  SDS-12% PAGE analysis of fractions obtained during affinity chromatography
purification of P. aeruginosa Upp.  The fusion protein was eluted with 2 ml of 10 mM
reduced glutathione.  Lanes:  1, molecular mass marker (ovalbumin, 52.2 kDa;  carbonic
anhydrase, 36.3 kDa;  soybean trypsin inhibitor, 30.2 kDa;  and lysozyme, 21.9 kDa);  2,
Eluate after first round of batch purification treated with thrombin protease showing
incomplete cleavage;  3, Eluate after second round of batch purification showing GST
tag;  4, Supernatant from second round of batch purification showing purified Upp
protein.









suggest PyrR to be a DNA-binding regulatory protein. To test this, a DNA-binding
EMSA was performed with purified PyrR protein using end-labeled DNA fragments
containing the promoter regions of the pyrR, pyrD, pyrE and pyrF genes.  The in vitro
assays were carried out in the absence and presence of orotate, OMP, UMP and PRPP,
which were considered to be potential ligands for the following reasons: (i) orotate is a
key intermediate in the pyrimidine pathway and the substrate for pyrE encoded OPRTase,
another control point in the biosynthetic pathway.  (ii) OMP is the product of the
OPRTase reaction but also serves as a substrate for OPRTase acting in reverse.  This
reverse reaction has been shown to be favored in E. coli and S. typhimurium (Jensen,
1982), although this equilibrium has not been studied in P. aeruginosa, it could be
assumed to be the same in Pseudomonas.  Therefore, OMP could serve as a signal
molecule to indicate high pyrimidine levels, (iii) UMP is the product of the biosynthetic
pathway and shown to act as a co-repressing molecule in B. subtilis.  When pyrimidine
levels are high, UMP binds to the B. subtilis PyrR enabling it to bind to the mRNA and
decrease expression of the pyr genes; no decrease in expression was observed in the
absence of UMP binding.  The binding of UMP to the B. subtilis PyrR has been shown by
crystal structure data to involve four key residues; Arg-138 (♦), Thr-156 (•), Thr-41 and
Val-162 (Φ).  The presence of the latter two of these residues in the P. aeruginosa PyrR
sequence (Fig. 34) suggested that UMP might also be a ligand for the P. aeruginosa PyrR
protein, and (iv) a conserved PRPP binding domain identified in the B. subtilis PyrR
sequence was also present in the P. aeruginosa PyrR sequence.  In addition, PRPP has
been shown to antagonize the RNA-binding capability of the B. subtilis PyrR protein.
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Results from the EMSA of purified PyrR with the upstream promoter region of the pyrR
gene (Fig. 49), showed that the PyrR protein bound to the DNA containing the upstream
sequence of the pyrR gene in the absence of any ligands (lane 2), and in the presence of
0.1 mM orotate (lane 3) or 0.1 mM UMP (lane 5). This was indicated by the retarded
electrophoretic mobility of the DNA/protein complex compared to the mobility of the
free DNA probe (lane 1).  In other words either, orotate and UMP were not ligands for
PyrR, or they bound to PyrR but did not affect or promote its ability to bind DNA.  The
addition of 0.1 mM OMP (lane 4) or 0.1 mM PRPP (lane 6) to the binding reaction
obstructed PyrR from binding to the pyrR DNA, establishing both PRPP and OMP as
ligands for the P. aeruginosa PyrR protein.  An EMSA using DNA fragments containing
the promoter regions of the biosynthetic genes, pyrD, pyrE and pyrF showed the PyrR
protein bound to all three genes (Figs. 50, 51, 52), respectively under the same conditions
as for the pyrR gene.  A DNA/protein complex was formed in the absence of any ligands
and in the presence of orotate or UMP, and the formation of the DNA/protein complex
was prevented in the presence of OMP or PRPP.
Since PyrR has been determined to be an activator protein for the pyrD, pyrE and
pyrF genes and a repressor protein for autoregulation, it was thought that the PyrR
protein would have a greater affinity for the pyr genes than for its own DNA.  To
determine the binding specificity of PyrR to its own DNA versus the DNA of the
downstream pyr genes, EMSA assays were performed with the DNA concentration held
constant at 5,000 cpm and varying the PyrR concentration from 0.1 µg to 5 µg (Figs. 55,
56).  The intensity of the bands were measured with a video densitometer using a
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Fig. 49.  Autoradiograph of a 4% polyacrylamide gel showing the DNA-binding EMSA
of purified PyrR with the pyrR promoter fragment used as the end-labeled probe.  All
reactions were carried out using 5,000 cpm of DNA and 13 nM purified PyrR protein.
Lanes: 1, DNA probe without protein;  2, DNA probe and PyrR;  3, DNA probe, PyrR
and 0.1 mM orotate;  4, DNA probe, PyrR and 0.1 mM OMP;  5, DNA probe, PyrR and
0.1 mM UMP;  6, DNA probe, PyrR and 0.1 mM PRPP;  7, DNA probe without protein.
Bound probe
Free probe
       1         2        3        4        5          6         7
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Fig. 50.  Autoradiograph of a 4% polyacrylamide gel showing the DNA-binding EMSA
of purified PyrR with the pyrD promoter fragment used as the end-labeled probe.  All
reactions were carried out using 5,000 cpm of DNA and 13 nM purified PyrR protein.
Lanes: 1, DNA probe without protein;  2, DNA probe and PyrR;  3, DNA probe, PyrR
and 0.1 mM orotate;  4, DNA probe, PyrR and 0.1 mM OMP;  5, DNA probe, PyrR and
0.1 mM UMP;  6, DNA probe, PyrR and 0.1 mM PRPP.




Fig. 51.  Autoradiograph of a 4% polyacrylamide gel showing the DNA-binding EMSA
of purified PyrR with the pyrE promoter fragment used as the end-labeled probe.  All
reactions were carried out using 5,000 cpm of DNA and 13 nM purified PyrR protein.
Lanes: 1, DNA probe without protein;  2, DNA probe and PyrR;  3, DNA probe, PyrR
and 0.1 mM orotate;  4, DNA probe, PyrR and 0.1 mM OMP;  5, DNA probe, PyrR and
0.1 mM UMP;  6, DNA probe, PyrR and 0.1 mM PRPP;  7, DNA probe without protein.
Free probe
Bound probe
          1         2         3        4         5         6       7
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Fig. 52.  Autoradiograph of a 4% polyacrylamide gel showing the DNA-binding EMSA
of purified PyrR with the pyrF promoter fragment used as the end-labeled probe.  All
reactions were carried out using 5,000 cpm of DNA and 13 nM purified PyrR protein.
Lanes: 1, DNA probe, PyrR and 0.1 mM PRPP;  2, DNA probe, PyrR and 0.1 mM UMP;
3, DNA probe, PyrR and 0.1 mM OMP;  4, DNA probe, PyrR and 0.1 mM orotate;  5,
DNA probe and PyrR;  6, DNA probe without protein.




NIH Image Version 1.61 program by Wayne Rasband.  The apparent dissociation
constants (Kd) were graphically determined based on the varying intensities of the shifted
bands (Fig. 57, 58).  An apparent Kd of 6.8 nM was determined for PyrR binding to pyrE
DNA compared to an apparent Kd value of 9.6 nM for binding of PyrR to pyrR DNA.
Hence a lower concentration of PyrR was required for binding to the pyrE DNA.  This
suggested that the PyrR protein had a greater affinity for pyrE, which also represented its
affinity for the other two downstream genes, pyrD and pyrF, compared to its affinity for
binding to pyrR for autoregulation.  The binding specificities of OMP and PRPP were
also determined by similar EMSA binding studies.  The DNA and PyrR concentrations
were held constant while the concentration of ligand was varied from 0.03 mM to 1 mM.
Results showed that OMP had a greater affinity for PyrR than for PRPP, since the lowest
concentration of 0.03 mM OMP prevented PyrR from binding to pyrR DNA (data not
shown) it can be assumed that the Kd for OMP is less than 30 µM.  A Kd of 35 µM was
determined for PRPP to PyrR (Fig. 59).  The intracellular concentration of PRPP is 9.0
µM (Traut, 1994), suggesting that PRPP only binds to PyrR when PRPP levels are high.
High intracellular PRPP levels are indicative of high purines and consequently high
pyrimidine levels, therefore the binding of PRPP to PyrR would prevent it from binding
to the downstream genes to activate their expression.  Since the maximum concentration
of PyrR protein used in these EMSA assays was only 13 nM, saturation of binding was
not achieved, therefore only the relative Kd values could be reported here.
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Fig. 53.  Autoradiograph of competitive binding EMSA of purified PyrR to pyrR end-
labeled DNA (5,000 cpm) in the presence of orotate versus PRPP.  The concentration of
PyrR and PRPP was held constant at 6.5 nM and 0.1 mM respectively.  The orotate
concentration was varied as stated.  Lanes:  1, DNA probe only;  2, DNA probe and
PyrR;  3, DNA probe, PyrR, PRPP and 1 mM orotate;  4, DNA probe, PyrR, PRPP and
0.5 mM orotate;  5, DNA probe, PyrR, PRPP and 0.25 mM orotate;  6, DNA probe, PyrR,
PRPP and 0.125 mM orotate;  7, DNA probe, PyrR, PRPP and 0.06 mM orotate;  8, DNA
probe, PyrR, PRPP and 0.03 mM orotate.
Free probe
Bound probe
                1          2        3        4         5        6        7         8
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Fig. 54.  Autoradiograph of competitive binding EMSA of purified PyrR to pyrR end-
labeled DNA (5,000 cpm) in the presence of UMP versus PRPP.  The concentration of
PyrR and PRPP was held constant at 6.5 nM and 0.1 mM respectively.  The UMP
concentration was varied as stated.  Lanes:  1, DNA probe only;  2, DNA probe and
PyrR;  3, DNA probe, PyrR, PRPP and 1 mM UMP;  4, DNA probe, PyrR, PRPP and 0.5
mM UMP;  5, DNA probe, PyrR, PRPP and 0.25 mM UMP;  6, DNA probe, PyrR, PRPP
and 0.125 mM UMP;  7, DNA probe, PyrR, PRPP and 0.06 mM UMP;  8, DNA probe,
PyrR, PRPP and 0.03 mM UMP.
Free probe
Bound probe
             1        2       3       4     5       6      7       8
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Fig. 55.  Autoradiograph of EMSA for specificity of binding of purified PyrR to pyrR
using 5,000 cpm of end-labeled DNA.  Lanes:  1, 13 nM PyrR;  2, 10.4 nM PyrR;  3, 7.8
nM PyrR;  4, 5.2 nM PyrR;  5, 2.6 nM PyrR;  6, 1.3 nM PyrR;  7, 0.65 nM PyrR;  8, 0.26
nM PyrR;  9, no protein.
Fig. 56.  Autoradiograph of EMSA for specificity of binding of purified PyrR to pyrE
using 5,000 cpm of end-labeled DNA.  Lanes:  1, 13 nM PyrR;  2, 10.4 nM PyrR;  3, 7.8
nM PyrR;  4, 5.2 nM PyrR;  5, 2.6 nM PyrR;  6, 1.3 nM PyrR;  7, 0.65 nM PyrR;  8, 0.26
nM PyrR;  9, no protein.
Bound probe
Free probe
1       2      3      4      5      6       7     8       9
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Fig. 57.  Determination of the dissociation constant (Kd) for PyrR on pyrE DNA by EMSA using purified PyrR protein.


















Fig. 58.  Graphical representation of the dissociation constant (Kd) for PyrR on pyrR DNA.


















Fig. 59.  Graphical representation of the dissociation constant (Kd) for PRPP on PyrR.



















The native molecular weight of the purified Pseudomonas PyrR was determined
by gel filtration chromatography in the absence or presence of the ligands OMP and
PRPP.  In general, two peaks were resolved by HPLC and a possible third peak was
detected but not fully resolved.  A fourth peak corresponding to the GST-PyrR fusion
present in the purified PyrR preparation was also detected (Fig. 60).  From a standard
curve (Fig. 61), the two resolved peaks corresponded to molecular masses averaging 20
kDa and 80 kDa.  Given the subunit size of the Pseudomonas PyrR was 20 kDa, the 80
kDa peak would represent a tetrameric aggregated form of the native protein.  In B.
subtilis, the more aggregated hexameric form of the PyrR protein is favored in the
presence of UMP and the less aggregated dimeric form in the presence of PRPP.  To test
if such was also the case with the Pseudomonas protein, the purified protein was pre-
incubated with OMP and PRPP prior to loading on to the gel filtration column.  Figures
62 and 63 showed that in Pseudomonas, the more aggregated tetrameric form was
favored in the presence of PRPP.  The addition of OMP, did not shift the equilibrium and
thus did not affect the molecular state of PyrR (data not shown).
Uracil phosphoribosyltransferase (UPRTase) assay.
UPRTase assays were performed as described in Materials and Methods and
analyzed by HPLC.  Figures 64 and 65 present uracil and orotate standards respectively.
It can be seen from the figures that optimal uracil detection is at 254 nm and orotate at
280 nm.  Since orotate is considered a key intermediate in pyrimidine regulation (Jensen,
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Fig. 60.  Chromatogram from gel filtration analysis of purified PyrR protein.  Retention
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Fig. 62.  Chromatogram from gel filtration analysis of purified PyrR protein pre-
incubated with 0.1 mM PRPP.  Retention times in minutes are shown below the peaks of
interest.
Fig. 63.  Chromatogram from gel filtration analysis of purified PyrR protein pre-



















1982), wild type Pseudomonas cells were grown with glucose as carbon source (Fig. 66),
in the absence and presence of excess orotate (Fig. 67), and with succinate as carbon
source (Fig. 68).  Chromatograms showed that UPRTase activity in Pseudomonas was
enhanced when cells were grown in the presence of excess exogenous orotate (Table 6).
However, UPRTase activity decreased when the cells were grown in succinate as the
carbon source.
The alignment of the P. aeruginosa PyrR with UPRTases from Pseudomonas, E.
coli and B. subtilis (Fig. 70) showed some homology between PyrR and the Upp proteins
from these organisms.  Since the B. subtilis PyrR protein has UPRTase activity, the
Pseudomonas PyrR protein was tested for UPRTase activity. Also, since PRPP and Mg2+
act as stabilizing substrates for UPRTase in E. coli, the purified Pseudomonas PyrR
protein was pre-incubated with PRPP and Mg2+ prior to assaying for UPRTase activity.
Despite sharing sequence homology with the Upp proteins, UPRTase activity was not
detected with the purified PyrR protein (Fig. 69).
Orotate phosphoribosyltransferase (OPRTase) assays.
OPRTase assays were performed as described in Materials and Methods using the
same samples used for the UPRTase assays mentioned above.  The assay was analyzed
by HPLC and the formation of the reaction product, OMP was detected at 280 nm.
Figures 71 and 72 present the UMP and OMP standards at 254 nm and 280 nm,
respectively.  Chromatograms from the assay (Figs. 73, 74, 75) showed no change in
OPRTase activities in wild type cells regardless of growth conditions.  In B. subtilis,
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UMP is the signal molecule for pyrimidine regulation and hence the PyrR protein from B.
subtilis displays nominal UPRTase activity.  Since the Pseudomonas PyrR protein did not
display UPRTase activity it was tested for OPRTase function, considering that in
Pseudomonas, orotate is a key regulatory intermediate (Jensen, 1982).  When aligned
with various OPRTases, the Pseudomonas PyrR protein showed nominal sequence
similarity (Fig. 77), yet it contained the OMP binding domain.  Despite this, as can be
seen from Figure 76, the Pseudomonas pyrR protein did not have any detectable
OPRTase activity.
Table 6.  HPLC assay data for UPRTase and OPRTase activity in P. aeruginosa wild
type cells grown under varying conditions.
Strain Genotype Growth Conditions Specific Activitya
(µmol/min/mg protein)
UPRTase OPRTase
PAO1 Wild type Glucose 46.9 33.8
PAO1 Wild type Glucose + 1mM orotate 60.9 28.8
PAO1 Wild type Succinate 21.1 20.0
a Specific activities were calculated based on the peak area of the product formed; UMP for UPRTase and
OMP for OPRTase.
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 Orotate decarboxylase assays.
Very few organisms that have the ability to deacrboxylate orotate to uracil have
been identified.  In Neurospora crassa, the enzyme isoorotate decarboxylase (IDCase)
removes the CO2 from isoorotate to yield uracil, and this reaction is the final step of a
recently identified thymidine salvage pathway (Smiley et al., 1999).  A similar reaction is
also found to occur in two strains of the Mycobacterium (Vitols et al., 1967) that can
utilize orotate as sole nitrogen source by decarboxylating it to uracil before the ring is
broken for nitrogen source (Vogels and Van der Drift, 1976).  To date, an orotate
decarboxylase has never been shown to be present in Pseudomonas.
A glance at Fig. 1 (de novo pathway) clearly shows that orotate cannot satisfy the
pyrimidine requirement of pyrE or pyrF mutants.  One way to test for an orotate
decarboxylase would be to see if a pyrE or pyrF mutant could grow on orotate.  To that
end, a recruited strain of a pyrE deletion mutant (MVP7404) was isolated as follows: 100
µl of a PAO8017 (crc-, pyrE-) culture was plated on Pseudomonas minimal medium, with
glucose as the carbon source and orotate as the pyrimidine source.  The plate was
incubated at 37°C until isolated colonies appeared (~ 5 days incubation).  A colony was
inoculated into Pseudomonas minimal broth with glucose and orotate and incubated with
shaking at 37°C.  If the culture reached an OD600 ~0.6 within 16 hr of incubation, this
meant that the cell had ‘recruited’ the ability to use orotate as a pyrimidine source,
indicating that an orotate decarboxylase enzyme may be present in Pseudomonas.  To
that end, orotate decarboxylase assays were performed as described in Materials and
Methods and analyzed by HPLC.  The recruited pyrE mutant (MVP7404) was grown
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under the conditions listed in Table 7.  Results showed a 5-fold conversion of orotate to
uracil when the cells were grown in excess exogenous orotate compared to the same cell
in the absence of exogenous orotate.  To further prove that uracil was indeed produced
from decarboxylating the orotate, the same reaction assays were analyzed for UPRTase
activity by the addition of PRPP and Mg2+ in vitro, and the product UMP was quantitated
(Table 8).  Calculated specific activities showed that uracil was made when orotate was
added to the reaction mix.  This was reflected by the 5-fold increase in UPRTase activity
observed when compared to the control reaction mixture.  The finding of this orotate
decarboxylase enzyme was novel in Pseudomonas and of great importance as this






Fig. 64.  Chromatogram of 0.1 mM uracil and 0.1
mM orotate standards detected at 254 nm.  Retention





Fig. 65.  Chromatogram of 0.1 mM uracil and 0.1
mM orotate standards detected at 280 nm.  Retention





Fig. 66.  Chromatogram of UPRTase
activity in wild type P. aeruginosa grown in






Fig. 67.  Chromatogram of UPRTase
activity in wild type P. aeruginosa grown in







Fig. 68.  Chromatogram of UPRTase assay
in wild type P. aeruginosa grown in




Fig.69 .  Chromatogram of UPRTase assay
of P. aeruginosa  purified PyrR protein.
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Fig. 70.  Sequence alignment of the Pseudomonas PyrR protein with various Upp proteins.
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Fig. 71.   Chromatogram of 0.1 mM UMP and 0.1 mM






Fig. 72.   Chromatogram of 0.1 mM UMP and 0.1 mM







Fig. 73.  Chromatogram of OPRTase activity in wild type






Fig.74 .  Chromatogram of OPRTase activity in wild type
P. aeruginosa grown in Pseudomonas mimimal medium







Fig. 75.   Chromatogram of OPRTase activity in wild




Fig. 76.  Chromatogram of OPRTase activity in P.
aeruginosa purified PyrR protein.
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Fig. 77.  Sequence alignment of the Pseudomonas PyrR proteins with various OPRTases.
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Table 7.  Orotate decarboxylase assay data from the recruited P. aeruginosa crc, pyrE





(µmol min-1 mg protein-1)
MVP7404 crc-, pyrE- Glucose 30.3
MVP7404 crc-, pyrE- Glucose + 1mM
orotate
153.3
a Specific activities were calculated from the peak areas of the uracil product formed.
Table 8.  Orotate decarboxylase and UPRTase assay data from the recruited P.
aeruginosa crc, pyrE mutant (MVP7404) grown with glucose and exogenous orotate.
Strain Genotype Specific Activity (µmol min-1 mg protein-1)a
PAO8017 crc-, pyrE- -MgCl2 +MgCl2 +PRPP +MgCl2
+PRPP
Orotate Decarboxylase 160.0 143.0 200.0 180.0
UPRTase 43.3 50.0 100.0 240.0
a Specific activities were calculated from the peak areas of the products formed; uracil for
orotate decarboxylase and UMP for UPRTase.
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Fig. 78.  Chromatogram from an orotate decarboxylase assay of wild type P. aeruginosa
grown in Pseudomonas minimal medium with glucose as the carbon source.  Retention






Fig. 79.  Chromatogram from an orotate decarboxylase assay of the recruited P.
aeruginosa crc, pyrE mutant (MVP7404) grown in Pseudomonas minimal medium with






Fig. 80.  Chromatogram from an orotate decarboxylase assay of the recruited P.
aeruginosa crc, pyrE mutant (MVP7404) grown in Pseudomonas minimal medium with
glucose as the carbon source and supplemented with exogenous orotate.  Retention times






Fig. 81.  Chromatogram from an orotate decarboxylase assay, with the addition of MgCl2
in the reaction mix, of the recruited P. aeruginosa crc, pyrE mutant (MVP7404) grown in
Pseudomonas minimal medium with glucose as the carbon source and supplemented with








Fig. 82.  Chromatogram from an orotate decarboxylase assay, with the addition of PRPP
in the reaction mix, of the recruited P. aeruginosa crc, pyrE mutant (MVP7404) grown in
Pseudomonas minimal medium with glucose as the carbon source and supplemented with







Fig. 83.  Chromatogram from an orotate decarboxylase assay, with the addition of MgCl2
and PRPP in the reaction mix, of the recruited P. aeruginosa crc, pyrE mutant
(MVP7404) grown in Pseudomonas minimal medium with glucose as the carbon source
and supplemented with exogenous orotate.  Retention times in minutes are shown below







5-fluoroorotate (5-FOA) plate assays.
When 5-FOA enters the cell and, the sequential action of the pyrE and pyrF
encoded enzymes, OPRTase and OMP decarboxylase respectively converts it to 5-
FUMP.  5-FUMP is toxic to the cell because it is ultimately incorporated into RNA as 5-
FUTP, the fluoro-analog of the ribonucleotide, UTP.  The presence of the fluoro group
causes mistranslation by the ribosome and thus kills the cell, creating a zone of killing.
The presence of a zone of killing was therefore indicative of 5-FOA entry into the cell
and its conversion to the toxic fluoronucleotide.  However, the absence of a zone of
killing suggested that either, the entry of 5-FOA into the cell was prevented, or 5-FOA
entered the cell but could not be metabolized to the toxic nucleotide level.   Plate assay
results of P. aeruginosa wild type cells using 0.2% glucose as the carbon and energy
source showed a zone of killing (Fig. 84a).  However, when 10 mM succinate was used
as the carbon and energy source, a zone of killing was not observed (Fig. 84b).  This
suggested that in the presence of succinate, wild type cells either did not allow entry of
orotate into the cell or could not metabolize the fluoroorotate, once in the cell.  Phibbs
and co-workers have shown the existence of catabolite repression control in
Pseudomonas.  This catabolite repression control involves the crc encoded Crc protein,
for which succinate has been shown to be the strongest repressing metabolite.  The 5-
FOA plate assays described above were repeated using a P. aeruginosa crc mutant strain
(PAO8023), to determine if Crc played a role in the entry of orotate and its metabolism
by the cell.  A zone of killing was observed when either glucose or succinate, was used as
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Fig. 84.  Effect of 5-Fluoroorotate on P. aeruginosa, AK903 grown in minimal medium




Fig. 85.  Effect of 5-Fluoroorotate on P. aeruginosa crc mutant, PAO8023 grown in





carbon and energy source (Figs. 85a, b), this suggested that in the absence of the Crc
protein, succinate no longer affected the uptake or metabolism of orotate by P.
aeruginosa.
Orotate as a pyrimidine source.
The ability of a pyrimidine auxotroph to utilize uracil or orotate as a pyrimidine
source was tested by growing P. aeruginosa pyrD- strain (PAO0114) on glucose or
succinate minimal (Table 9).  A glance at Table 9 shows that uracil satisfied the
pyrimidine requirement when either glucose or succinate was used as the carbon source,
while orotate satisfied the pyrimidine requirement in glucose, but not in succinate.  This
suggested that orotate utilization as sole pyrimidine source (transport or metabolism)
prevented by succinate.
Isolation of out mutants.
The transport of succinate into the cell has been shown in E. coli, S. typhimurium
(Baker et al., 1996), and Sinorhizobium meliloti (Yurgel et al., 2000) to be via the DctA
protein, a high-affinity permease that is part of the dicarboxylate transport (Dct) system.
The study in S. meliloti (Yurgel et al., 2000) recently established that the Dct transport
system also enables the entry of orotate, a monocarboxylate, into the cell.  Mutants
isolated based on their resistance to 5-FOA, known as out mutants, because of their
inability to utilize orotate as sole pyrimidine source have been mapped to the dctA locus
(Baker et al. 1996).  Figure 86 show that the P. aeruginosa DctA sequence has amino
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Table 9.  The ability of a P. aeruginosa pyrD mutant to utilize succinate as a carbon and
energy source and orotate as a pyrmidine source.







mutants were isolated using P. aeruginosa wild type cells (MVP7402) and a P.
aeruginosa pyrD auxotroph (MVP7403).  Mutants isolated from wild type cells were
tested for their ability to use succinate as a carbon and energy source, and the mutants
isolated from the pyrD- strain were tested for the ability to use orotate as the pyrimidine
source (Table. 9).  Results showed that the mutant strains, MVP7402 and MVP7403 were
able to grow on succinate as the carbon source, though not as well as on glucose. This
suggested that although the Dct system is the primary mode of transport for succinate,
there is an alternative mechanism by which the cell could acquire succinate.  In addition,
orotate could not satisfy the pyrimidine requirement in the mutants isolated from the
pyrD- auxotroph (MVP7403), which suggested that the Dct system was present in
Pseudomonas and was the only mode by which orotate could enter the cell.
Quantitative radiolabel orotate assay.
In E. coli and S. typhimurium succinate was found to compete with orotate for
entry into the cell (Baker et al. 1996).  In order to test this in P. aeruginosa, a competitive
radiolabeled orotate entry assay was performed.  The percent of radiolabeled orotate
entering resting cells was measured in wild type grown in glucose or succinate as the
both in the absence and presence of exogenous orotate.  As Fig. 87 shows, there was no
difference in the amount of orotate entering the cells when grown in glucose or succinate
alone.  However, approximately 3 times more radiolabeled orotate entered the wild type
cells grown in succinate in the presence of 1 mM exogenous orotate compared to those
grown in glucose and orotate (Fig. 87).  This suggested that expression of the dctA gene
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Fig. 86.  Sequence alignment of the P. aeruginosa DctA protein with various other DctA proteins.
                      *        20         *        40         *        60         *        80
P_aerugino : ---------------------MTKQPFYKSLYVQVLVAIAIGIALGHWYPETAVAMKPFGDGFVKLIKMAIAPIIFCTVVTGIAG :  64
E_coli     : ----------------------MKTSLFKSLYFQVLTAIAIGILLGHFYPEIGEQMKPLGDGFVKLIKMIIAPVIFCTVVTGIAG :  63
S_typhimur : ----------------------MKTSLFKSLYFQVLTAIAIGILLGHYYPELGAQMKPLGDAFVKLIKMIIAPVIFCTVVTGIAG :  63
R_legumino : ---------MIAAPLDAVAGSKGKKPFYSHLYVQVLVAIAAGILLGHFYPELGTQLKPLGDAFIKLVKMIIAPVIFLTVATGIAG :  76
                 *       100         *       120         *       140         *       160         *
P_aerugino : MQSMKSVGKTGGMALLYFEVVSTVALIIGLVVVNVVQPGAGMHVDPNTLDTSKIAAYAAAGEKQSTVDFLMNVIPGTVVGAFANG : 149
E_coli     : MESMKAVGRTGAVALLYFEIVSTIALIIGLIIVNVVQPGAGMNVDPATLDAKAVAVYADQAKDQGIVAFIMDVIPASVIGAFASG : 148
S_typhimur : MESMKAVGRTGAVALLYFEIVSTIALIIGLIIVNVVQPGAGMNVDPATLDAQAVAVYAAQAKEQGIIAFLMDVIPGSVIGAFASG : 148
R_legumino : MSDLQKVGRVAGKAMLYFLTFSTLALIIGLIVANVVQPGAGMNIDPASLDPAAVATFAAKAHEQSIVGFLTNIIPTTIVGAFADG : 161
                    180         *       200         *       220         *       240         *
P_aerugino : DILQVLFFSVLFGYALHRLGSYGKPVFEFIERVSHVMFNIINVIMKVAPIGAFGAMAFTIGAYGVGSLVQLGQLMLCFYITCILF : 234
E_coli     : NILQVLLFAVLFGFALHRLGSKGQLIFNVIESFSQVIFGIINMIMRLAPIGAFGAMAFTIGKYGVGTLVQLGQLIICFYITCILF : 233
S_typhimur : NILQVLLFAVLFGFALHRLGSKGQLIFNVIESFSQVIFGIINMIMRLAPIGAFGAMAFTIGKYGVGSLVQLGQLIICFYITCILF : 233
R_legumino : DILQVLFFSVLFGIALAMVGEKGEQVVNFLNSLTAPVFKLVAILMKAAPIGAFGAMAFTIGKYGVGSIANLAMLIGTFYITSLLF : 246
               260         *       280         *       300         *       320         *       340
P_aerugino : VLIVLGGIARAHGFSILRFIRYIREELLIVLGTSSSESALPRMIDKMEKLGCNKSVVGLVIPTGYSFNLDGTSIYLTMAAVFIAQ : 319
E_coli     : VVLVLGSIAKATGFSIFKFIRYIREELLIVLGTSSSESALPRMLDKMEKLGCRKSVVGLVIPTGYSFNLDGTSIYLTMAAVFIAQ : 318
S_typhimur : VVVVLGTIARVTGFSIFKFIRYIREELLIVLGTSSSESALPRMLDKMEKLGCRKSVVGLVIPTGYSFNLDGTSIYLTMAAVFIAQ : 318
R_legumino : VFIVLGAVARYNGFSIVALLRYIKEELLLVLGTSSSEAALPGLMNKMEKAGCKRSVVGLVIPTGYSFNLDGTNIYMTLAALFIAQ : 331
                      *       360         *       380         *       400         *       420
P_aerugino : ATDTPMDITHQITLLLVLLIASKGAAGVTGSGFIVLAATLSAVGHLPVAGLALILGIDRFMSEARALTNLVGNGVATVVVSKWCK : 404
E_coli     : ATNSQMDIVHQITLLIVLLLSSKGAAGVTGSGFIVLAATLSAVGHLPVAGLALILGIDRFMSEARALTNLVGNGVATIVVAKWVK : 403
S_typhimur : ATNSHMDIFHQITLLVVLLLSSKGAAGVTGSGFIVLAATISAVGHLPVAGLALILGIDRFMSEARALTNLVGNGVATVVVAKWVK : 403
R_legumino : AG-IHLSWGDQILLLLVAMLSSKGAAGITGAGFITLAATLSVVPSVPVAGMALILGIDRFMSECRALTNLVGNAVATIVVARWEN : 415
                 *       440         *
P_aerugino : QLDEGTLQRELAGEGNASSPASDIPVGGREAV : 436
E_coli     : ELDHKKLDDVLN---NRAPDGKTHELSS---- : 428
S_typhimur : ELDHQKLDDVLN---NRAPDGKTHEISS---- : 428
R_legumino : ELDTVQLAAALG--GQTGEDTSAAGLQPAE-- : 443
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Table 10.  The ability of P. aeruginosa out mutants (DctA-) to utilize succinate as a











Glucose - + + + Not tested
Succinate - + + Not tested
Glucose Uracil Not tested + + +
Succinate Uracil Not tested +
Glucose Orotate Not tested -
Succinate Orotate Not tested -
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acid similarity and identity to other DctA sequences including that of E. coli.  To
ascertain the presence of a functional Dct transport system in Pseudomonas, out (DctA-)
in P. aeruginosa was induced by orotate in the presence of  succinate as the carbon
source.  This finding was unique to the P. aeruginosa DctA transport system. Previous
data from 5-fluoroorotate plate assays showed that the Crc protein had an effect on either
(i) the entry of orotate or (ii) the metabolism of orotate, in cells grown in succinate.  To
determine if this effect by the Crc protein was at the level of orotate entry or orotate
metabolism, the same radiolabeled orotate assay was repeated using the crc, pyrE mutant
strain (PAO8023).  Fig. 87 shows that the Crc protein affect the ability of orotate to enter
the cell when either glucose or succinate was the carbon source.  Therefore, it is thought
that Crc affects the metabolism of orotate once in the cell, rather than its entry into the
cell as the previously suggested by the 5-FOA plate assays where a zone of killing was
observed in a crc mutant and no zone of killing observed in the isogenic wild type strain.
Effect of Crc on pyrimidine gene expression.
The Crc protein is a global regulator known to regulate a number of biosynthetic
and catabolic pathways in Pseudomonas (Collier et al., 1996).  To determine if Crc
played a role in pyrimidine metabolism, the pyr genes were assayed in a P. aeruginosa
wild type and compared to those in an isogenic crc- mutant.  Cells were grown in
succinate, in the absence and presence of orotate (Table 11).  There was a decrease in
pyrE expression for wild type cells grown in excess of orotate compared to those grown
without orotate while pyrE expression in the crc mutant cells was not affected by orotate.
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Fig. 87.  Effect of excess orotate in growth medium on entry of radiolabeled orotate into
P. aeruginosa wild type cells grown in glucose or succinate minimal medium in the




























This suggess that Crc affects pyrE expression only under conditions of high orotate.  A
similar result was obtained for a crc mutant strain harboring the crc gene on a plasmid
 (Table 11).  Here, there was a four-fold decrease in pyrE expression under the same high
levels of orotate.  This effect was not observed for the expression of the other pyr genes
tested, which suggests that Crc played a role only in the metabolism of orotate because of
pyrE expression.  Moreover, when the cells grown in glucose (Table 12), this effect by
Crc was not observed on expression of pyrE.  This suggests that Crc only comes into play
when succinate is used as the carbon and energy source.
Effect of Crc on pyrR gene expression.
To determine if the Crc protein affected expression of the pyrR gene at the level
of transcription, the pyrR::lacZ transcriptional fusion, pMVP50 was assayed for β-
galactosidase activity in wild type P. aeruginosa and its isogenic crc mutant, PAO8020
(Table 13 and Fig. 88).  The level of β-galactosidase activity was the same in the P.
aeruginosa wild type strain and the isogenic crc mutant strain.  Thus, the Crc protein did
not effect transcription of the pyrR message most likely because the Crc protein did not
bind to DNA.
Although no effect was observed by Crc at the level of transcription, the
expression of BkdR, a transcriptional activator protein of the branched-chain keto acid
dehydrogenase (BCKAD) operon, is negatively regulated by Crc (Hester et al., 2000a, b).
This suggests that the mechanism of regulation of bkdR occurs at the posttranscriptional
level.  It was therefore important to ascertain if the same phenomenon applied for pyrR.
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Accordingly, a pyrR::lacZ translational fusion, pMVP52 was expressed in a P.
aeruginosa wild type strain and a crc mutant strain and assayed for β-galactosidase
activity (Table 14 and Fig. 89) to determine if this was also the case for the expression of
PyrR.  When both strains were grown in glucose, there was no change in the amount of
PyrR expressed.  However, when the cells were grown in succinate, there was a two-fold
increase in PyrR in the crc mutant (Fig. 89).  This suggested that Crc acted
posttranscriptionally in regulating PyrR levels when succinate is the carbon source.  The
Crc protein shares sequence similarity with exonucleases, and although it does not appear
to have endo- or exonuclease activity, it has been shown to possess all the necessary
structural features to cleave a phosphodiester bond (MacGregor et al., 1996).  Therefore,
it is possible that the Crc protein exerts its effect by acting on secondary RNA structure
(i.e. dsRNA) thereby affecting the translational efficiency or the stability (i.e. half-life) of
functional mRNA (Hester et al., 2000b).  The pyrR promoter readily forms a stable stem
loop structure sequesters the Shine-Dalgarno sequence and AUG start codon, so that it is
probable that the Crc protein cleaves the mRNA at the Shine-Dalgarno sequence thus
disrupting the ribosomal binding site.  This would then cause a decrease in amount of
PyrR protein translated.
158
Table 11.  Pyrimidine gene expression in P. aeruginosa a wild type, in a crc mutant and in a crc mutant harboring the crc+
gene on a plasmid.  Cells were grown in succinate as the carbon and energy source in the presence and absence of exogenous
orotate.





PAO1 Wild type Succinate 474.0 556.0 14.0 16.0 11.0
PAO1 Wild type Succinate + 1mM
Orotate
714.0 375.0 8.0 7.0 10.0
PAO8020 crc- Succinate 476.0 571.0 12.0 8.0 11.0
PAO8020 crc- Succinate + 1mM
Orotate
444.0 500.0 9.0 5.0 22.0
PAO8020 crc- (crc+) Succinate 410.0 42.0 18.0 175.0 35.0
PAO8020 crc- (crc+) Succinate + 1mM
Orotate
365.0 84.0 27.0 40.0 35.0
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Table 12.  Pyrimidine gene expression in P. aeruginosa a wild type, in a crc mutant and in a crc mutant harboring the crc+
gene on a plasmid.  Cells were grown in glucose as the carbon and energy source in the presence and absence of exogenous
orotate.
Strain Genotype Growth Conditions Specific Activity (µmol min-1 mg protein-1)
ATCase DHOase OPRTase
PAO1 Wild type Glucose 450.0 75.0 30.0
PAO1 Wild type Glucose + 1mM Orotate 419.3 80.6 116.1
PAO8020 crc- Glucose 354.8 112.9 77.4
PAO8020 crc- Glucose + 1mM Orotate 333.3 104.2 362.5
PAO8020 crc- (crc+) Glucose 250.0 66.7 176.6
PAO8020 crc- (crc+) Glucose + 1mM Orotate 450.0 166.7 218.3
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Table 13. β-galactosidase activity measurements of pyrR::lacZ reporter gene fusions in
wild type strain AK903 and crc deletion strain PAO8020 under different conditions of
growth.







pyrR::lacZ AK903 Wild type 330.5 330.2 319.8 353.3
pyrR::lacZ PAO 8020 crc - 284.0 308.5 369.1 404.3
a One unit of  β-galactosidase hydrolyzed 1 nmol of o-nitrophenol min-1 mg of protein-1.













































Table 14. β-galactosidase activity measurements of pyrR::lacZ translational gene fusions
in wild type strain AK903 and crc deletion strain PAO 8020 under different conditions of
growth.







pyrR::lacZ AK903 Wild type 258.0 258.2 321.9 300.1
pyrR::lacZ PAO 8020 crc - 295.4 314.8 606.5 603.8
a One unit of  β-galactosidase hydrolyzed 1 nmol of o-nitrophenol min-1 mg of protein-1.










































Based on data from this study, the following mechanism of action by the PyrR
and Crc proteins is proposed.  The mechanistic pathway begins with the PyrR protein
being expressed at low levels, which is achieved by having the Shine-Dalgarno sequence
sequestered within a stable stem-loop formation.  Such a secondary structure has been
shown to down-regulate translation of a protein by 10-100 fold (Yarchuk et al., 1992).
The PyrR protein represses its own expression by binding to the DNA upstream of the
pyrR coding sequence.  In this instance, basal level expression of the pyrBC' genes is
observed through activity of only the P2 promoter.  The presence of the P2 promoter
ensures continual expression of the pyrBC' genes, guaranteeing continual formation of
carbamoylaspartate, which is then converted to dihydroorotate by the action of ATCase.
Dihydroorotate has been shown to be a starting compound for the synthesis of pyoverdin,
an important siderophore in Pseudomonas (Maksimova et al., 1993) and an obligate
requirement for pathogenicity.
As the flow through the biosynthetic pathway continues and the cellular levels of
pyrimidines increase, there is an accumulation of endogenous orotate brought about by
the activation of the pyrD gene by PyrR.  As pointed out by Jensen (1982), the flux
through the pathway is dependent upon the accumulation of orotate within the cell
(Jensen, 1982).  In Pseudomonas, orotate accumulation occurs under several
physiological conditions.  For example, (i) the pyrE and crc genes share the same
promoter region.  Phibbs and co-workers (2000a) have shown that the Crc protein is
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constitutively expressed and that this expression is greater in cells grown in succinate.
(ii) Wang et al. (1999) have determined the dissociation constants of the substrates for
OPRTase to be 280 µM for orotate and 33 µM for PRPP.  This suggests that intracellular
levels of orotate must to reach at least 280 µM in order to be converted to OMP.  (iii)
Tom West and co-workers have shown that orotate induces expression of pyrC.  Such an
induction would also increase endogenous levels of dihydroorotate.
We believe that flow through the pyrimidine biosynthetic pathway is also
dependent on the ratio of unbound PyrR versus PyrR bound by OMP which can no longer
bind DNA.  When pyrimidine levels are limited, PyrR is made in a form that activates
expression of the downstream pyr genes, pyrD, pyrE, and pyrF (monomeric state).  When
the concentration of PyrR is high, the protein dimerizes and acts as a repressor for
autoregulation.  Sequence alignment of the DNA fragments used as probes for EMSA,
revealed a 9 bp conserved sequence ATGSSCSCC that could be the putative regulatory
element for binding of PyrR (Fig. 90).  This 9 bp consensus is appropriately located
upstream of the -10 and -35 promoter elements of the pyrD, pyrE and pyrF genes (Fig.
90).  This positioning is characteristic of activator binding sites.  This same consensus
sequence was also identified in the region upstream of the pyrR gene (Fig. 90).
Interestingly, the sequence is present as an imperfect inverted repeat, separated by 11 bp,
moreover, it is situated within the -10 and -35 pyrR promoter elements, which is
trademark of repressor binding sites.  This inverted repeat being separated by 11 bp
represents one turn of the helix suggesting that the PyrR protein binds to the pyrR
repression site as a dimer, but binds to the activation sites as a monomer.  However, this
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consensus was not identified in the DNA sequence upstream of the pyrC gene (encoding
dihydroorotase) suggesting that perhaps pyrC expression is under a different form of
regulation, one that is not mediated by PyrR.
In the absence of ligands, equilibrium for the native state of PyrR is
predominantly between the monomeric and dimeric forms, ensuring continued activation
of the pathway, therefore PyrR must be made at low levels. The P. aeruginosa PyrR
protein was found to shift between a monomeric, (dimeric) and tetrameric molecular
state.  The tetrameric state is favored in high PRPP concentrations and under such
cellular conditions PRPP binds to PyrR causing a conformational shift to the aggregated
tetrameric state.   It is possible that this conformational shift either obstructs the DNA
binding domain or the DNA binding domain is no longer accessible.  The role of PyrR
when bound by PRPP (PyrR in its tetrameric form) is yet unclear and is currently under
investigation.  However, this study has shown that PyrR in this aggregated form does not
bind to DNA.  Though the presence of OMP did not shift the PyrR equilibrium, the pyrF
gene product, OMP decarboxylase has been shown to be a very proficient enzyme (Harris
et al., 2000).  Moreover, the dissociation constant of OMP for OPRTase is 3 µM (Wang
et al., 1999) compared to 280 µM for orotate.  It is therefore very likely that high levels
of pyrimidines would lead to accumulation of OMP.  When OMP accumulates, it binds to
PyrR and abolishes the DNA binding capability of the PyrR protein thereby preventing
further activation of the downstream pyr genes.  However, it is proposed that the
biosynthetic pathway will be turned on again when the ratio of unbound PyrR exceeds
that of OMP bound PyrR.  This situation would only arise when pyrimidines availability
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is limited.  It must be noted that PyrR bound by OMP also prevents autoregulation.  The
consequent increase in expression of PyrR further facilitates the change in ratio of
unbound to OMP bound protein, in order to activate the pathway again.
In Pseudomonas, succinate is the preferred carbon source thus the cells have a
faster growth rate.  Phibbs and co-workers (2000b) have also shown that expression of
the Crc protein is greater when cells are grown in succinate as the carbon source, this
leads to an increase in Crc bound orotate and therefore a decrease in levels of PyrR.
Moreover, expression of the DctA transport protein is induced in the presence of high
levels of exogenous orotate when succinate is used as the carbon source.  This induction
of the Dct transport system by orotate is novel as such a phenomenon has not been
reported in other organisms. In addition, when pyrimidine levels are high, the Crc protein
bound by orotate, cleaves the secondary structure of the pyrRBC' mRNA such that the
ribosomal binding site is disrupted (Fig. 91).  This results in a decrease in translation of
PyrR and since the PyrR protein is an activator for pyrD, pyrE and pyrF, expression of
these genes also decreases causing a reduction in the pyrimidine pools.
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A pyrD   agcgaggATGGCCGCCtgctggcgc
pyrE   cgcataaATGGCCCCCaaatcacgt
pyrF   tgcgacaATGCGCGCCgttttcgat
B pyrR
   ttgacccATGGCAGCCggcacgccgccGTTTGCCATtat
consensus   ATGSSCSCC
    
Fig. 90.  Alignment of potential regulatory sequence elements identified upstream of the
genes regulated by the PyrR protein. The most conserved nucleotide positions are shaded.
A consensus deduced from these elements is indicated using the GCG code for the
degenerated nucleotide positions. (A) Activation sequence for the pyrD, pyrE and pyrF
genes. (B) Repression sequence for the pyrR gene. An imperfect inverted repeat sequence
separated by 11 bp is shown within the block arrows. The pyrR –10 and –35 promoter
regions are underlined.
←  11 bp  →
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